Yue7的个人主页 - 老虎社区

Yue7

Yue7

Yue Shunxiang

IP属地：未知

8关注

0粉丝

0主题

0勋章

2021-12-24

Cool

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>

2021-12-24

Go9oooooood

Intel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote>

2021-12-24

Cool

抱歉，原内容已删除

2021-12-24

Cool

Stocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote>

2021-12-16

Good

@46d9935c:2021年迄今录得机构净流入最高的20只股票回报率为32%

2021-11-01

Share

@小虎活动:[Halloween Game] Trade or Treat!

2021-11-01

Share

@小虎活动:[Halloween Game] Trade or Treat!

2021-06-18

Cool

抱歉，原内容已删除

2021-06-18

Nice

Alibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote>

2021-06-12

Please read...

2021-04-03

Nicee

抱歉，原内容已删除

2021-04-02

$Airbnb, Inc.(ABNB)$oh no

2021-04-02

Goooooddd

抱歉，原内容已删除

2021-03-26

Gooood

抱歉，原内容已删除

2021-03-24

Coool

These Stocks Are Set to Benefit from Intel’s $20 Billion Manufacturing Plan<blockquote>这些股票将受益于英特尔200亿美元的制造计划</blockquote>

2021-03-23

Buyyy

2021-03-23

I see. Cool

抱歉，原内容已删除

2021-03-23

Cool

抱歉，原内容已删除

2021-03-22

Goodfdf

2021-03-22

Good

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3562111968746343","uuid":"3562111968746343","gmtCreate":1599018283888,"gmtModify":1610159468522,"name":"Yue7","pinyin":"yue7","introduction":"","introductionEn":"","signature":"Yue Shunxiang","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":29,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.62%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":698952783,"gmtCreate":1640286687678,"gmtModify":1640286687754,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698952783","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=zh_CN&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">SeattleTimes</strong><span class=\"h-time small\">2021-12-23 22:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">SeattleTimes</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698952511,"gmtCreate":1640286571653,"gmtModify":1640286571653,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Go9oooooood","listText":"Go9oooooood","text":"Go9oooooood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698952511","repostId":"1152565085","repostType":4,"repost":{"id":"1152565085","kind":"news","pubTimestamp":1640272176,"share":"https://www.laohu8.com/m/news/1152565085?lang=zh_CN&edition=full","pubTime":"2021-12-23 23:09","market":"us","language":"en","title":"Intel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152565085","media":"Bloomberg","summary":"(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in Fran","content":"<p>(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations.</p><p><blockquote>（彭博社）-据知情人士透露，英特尔公司在全球范围内提高产能的努力将包括在法国和意大利增加工厂，以及在德国建立一个主要生产基地。</blockquote></p><p> France will be home to a research and design center, and Italy will be the location of a test and assembly factory, according to the people, who asked not to be identified because the plan hasn’t been announced. The main wafer fabrication plant, or fab, will likely be built in Germany, according to the people. Altogether, the expansion will cost tens of billions of dollars.</p><p><blockquote>据知情人士透露，法国将成为研究和设计中心的所在地，意大利将成为测试和组装工厂的所在地。由于该计划尚未公布，这些知情人士要求匿名。据知情人士透露，主要的晶圆制造厂（fab）可能会建在德国。总的来说，扩建将耗资数百亿美元。</blockquote></p><p> Chief Executive Officer Pat Gelsinger is trying to restore the world’s largest chipmaker to its former glory. The company has lost its technological edge to rivals and ceded market share -- something the spending binge is meant to address. Gelsinger also wants to bring more production back to the U.S. and Europe, counterbalancing Asia’s manufacturing dominance.</p><p><blockquote>首席执行官帕特·基辛格(Pat Gelsinger)正试图让这家全球最大的芯片制造商恢复昔日的辉煌。该公司已经将技术优势输给了竞争对手，并放弃了市场份额——这正是支出狂潮旨在解决的问题。基辛格还希望将更多生产带回美国和欧洲，抵消亚洲的制造业主导地位。</blockquote></p><p> Representatives of the French, German and Italian governments declined to comment, as did Intel spokespeople in Europe and the U.S.</p><p><blockquote>法国、德国和意大利政府代表拒绝置评，英特尔在欧洲和美国的发言人也拒绝置评。</blockquote></p><p> For Europe, the move would slow its decline as a manufacturing base in the $400 billion chip industry. The U.S. company has an existing plant in Ireland and there are older former Advanced Micro Devices Inc. processor factories that are owned by Globalfoundries Inc. in Dresden, Germany. But European manufacturers typically don’t make the kind of advanced logic chips that are regarded as the state of the art in the industry.</p><p><blockquote>对于欧洲来说，此举将减缓其作为4000亿美元芯片行业制造基地的衰落。这家美国公司在爱尔兰有一家现有工厂，在德国德累斯顿还有Globalfoundries Inc.拥有的较老的前Advanced Micro Devices Inc.处理器工厂。但欧洲制造商通常不生产被视为业内最先进的先进逻辑芯片。</blockquote></p><p> NXP Semiconductors NV and STMicroelectronics NV are the continent’s two largest homegrown chipmakers. They focus on parts for cars and other equipment -- rather than the advanced computer processors that are Intel’s specialty.</p><p><blockquote>恩智浦半导体公司和意法半导体公司是非洲大陆最大的两家本土芯片制造商。他们专注于汽车和其他设备的零部件，而不是英特尔擅长的先进计算机处理器。</blockquote></p><p> A global chip shortage also has renewed concerns about the concentration of production in Asia. Manufacturers such as Taiwan Semiconductor Manufacturing Co. and South Korea’s Samsung Electronics Co. have grown increasingly deft at producing chips, forcing Intel to play catch-up. Gelsinger has argued that spreading manufacturing around the world will help avoid the kinds of supply constraints that have hobbled whole industries this year, including automakers.</p><p><blockquote>全球芯片短缺也重新引发了人们对生产集中在亚洲的担忧。台积电公司和三星电子公司等制造商在生产芯片方面越来越熟练，迫使英特尔奋起直追。基辛格认为，将制造业扩展到世界各地将有助于避免今年阻碍包括汽车制造商在内的整个行业的供应限制。</blockquote></p><p> Part of Gelsinger’s plan is to build factories that make chips for other companies, directly rivaling TSMC in the so-called foundry business. Until now, Intel has typically only manufactured chips of its own design.</p><p><blockquote>基辛格计划的一部分是建立为其他公司制造芯片的工厂，在所谓的代工业务上直接与台积电竞争。到目前为止，英特尔通常只制造自己设计的芯片。</blockquote></p><p> To help fund his ambitions, he’s called on lawmakers on both sides of the Atlantic to give public money in the form of tax breaks and grants to chipmakers willing to build plants in Europe and the U.S.</p><p><blockquote>为了资助他的雄心，他呼吁大西洋两岸的立法者以税收减免和拨款的形式向愿意在欧洲和美国建厂的芯片制造商提供公共资金。</blockquote></p><p> By spreading around Intel’s spending, Gelsinger may be trying to placate as many EU members as he can to try to make sure that none of them try to object any central funding that’s made available. But the plans aren’t final yet. The mega-fab will likely be built in Saxony, with German regions of Saxony-Anhalt and Bavaria also in the running for the new factory.</p><p><blockquote>通过分散英特尔的支出，基辛格可能试图安抚尽可能多的欧盟成员国，以确保他们中没有人试图反对任何可用的中央资金。但是计划还没有最终确定。该大型工厂可能会建在萨克森州，德国萨克森-安哈尔特州和巴伐利亚州也在争夺新工厂。</blockquote></p><p> Intel’s ambitious new ventures could bring thousands of jobs. The company is also planning to create 4,000 jobs in Malaysia via a $7.1 billion investment in new chip packaging facilities.</p><p><blockquote>英特尔雄心勃勃的新企业可能会带来数千个就业机会。该公司还计划通过投资71亿美元建设新的芯片封装设施，在马来西亚创造4,000个就业岗位。</blockquote></p><p> Intel’s shares increased 1.2% in early trading Thursday.</p><p><blockquote>英特尔股价周四早盘上涨1.2%。</blockquote></p><p> Even with the potential government help, Intel is budgeting as much as $28 billion for new plants and equipment in 2022, up from roughly $18 billion this year. The spending plans have jarred investors, who worry about the toll on profit. But the massive increase in expenditures will only put Intel on course to keep up with TSMC and Samsung’s spending.</p><p><blockquote>即使有政府的潜在帮助，英特尔2022年的新工厂和设备预算仍高达280亿美元，高于今年的约180亿美元。这些支出计划令投资者感到不安，他们担心利润会受到影响。但支出的大幅增加只会让英特尔跟上台积电和三星的支出。</blockquote></p><p> Shares of Intel, based in Santa Clara, California, have gained just 2.3% this year -- even as its peers have enjoyed boom times. The Philadelphia Stock Exchange Semiconductor Index has climbed 39%, with companies such as Nvidia Corp. more than doubling.</p><p><blockquote>总部位于加利福尼亚州圣克拉拉的英特尔股价今年仅上涨了2.3%，尽管其同行经历了繁荣时期。费城证券交易所半导体指数上涨了39%，英伟达公司等公司的股价上涨了一倍多。</blockquote></p><p> State-of-the art chip production plants cost more than $20 billion, and their most expensive component -- machinery -- is usually obsolete within five years. The German plant could have a price tag in that range. The Italian test and assembly plant, meanwhile, will cost around $10 billion. Intel and government officials there are still negotiating on the site, with Sicily being one area under consideration, according to one of the people familiar with the situation.</p><p><blockquote>最先进的芯片生产厂耗资超过200亿美元，其最昂贵的部件——机械——通常会在五年内过时。德国工厂的价格标签可能在这个范围内。与此同时，意大利测试和装配厂将耗资约100亿美元。据一位知情人士透露，英特尔和那里的政府官员仍在就该地点进行谈判，西西里岛是正在考虑的地区之一。</blockquote></p><p> The French R&amp;D center may be built in either Paris or Grenoble, according to another person. Such facilities typically cost only a fraction of the amount needed to build a factory.</p><p><blockquote>另一位人士称，法国研发中心可能建在巴黎或格勒诺布尔。此类设施的成本通常仅为建造工厂所需费用的一小部分。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-23 23:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations.</p><p><blockquote>（彭博社）-据知情人士透露，英特尔公司在全球范围内提高产能的努力将包括在法国和意大利增加工厂，以及在德国建立一个主要生产基地。</blockquote></p><p> France will be home to a research and design center, and Italy will be the location of a test and assembly factory, according to the people, who asked not to be identified because the plan hasn’t been announced. The main wafer fabrication plant, or fab, will likely be built in Germany, according to the people. Altogether, the expansion will cost tens of billions of dollars.</p><p><blockquote>据知情人士透露，法国将成为研究和设计中心的所在地，意大利将成为测试和组装工厂的所在地。由于该计划尚未公布，这些知情人士要求匿名。据知情人士透露，主要的晶圆制造厂（fab）可能会建在德国。总的来说，扩建将耗资数百亿美元。</blockquote></p><p> Chief Executive Officer Pat Gelsinger is trying to restore the world’s largest chipmaker to its former glory. The company has lost its technological edge to rivals and ceded market share -- something the spending binge is meant to address. Gelsinger also wants to bring more production back to the U.S. and Europe, counterbalancing Asia’s manufacturing dominance.</p><p><blockquote>首席执行官帕特·基辛格(Pat Gelsinger)正试图让这家全球最大的芯片制造商恢复昔日的辉煌。该公司已经将技术优势输给了竞争对手，并放弃了市场份额——这正是支出狂潮旨在解决的问题。基辛格还希望将更多生产带回美国和欧洲，抵消亚洲的制造业主导地位。</blockquote></p><p> Representatives of the French, German and Italian governments declined to comment, as did Intel spokespeople in Europe and the U.S.</p><p><blockquote>法国、德国和意大利政府代表拒绝置评，英特尔在欧洲和美国的发言人也拒绝置评。</blockquote></p><p> For Europe, the move would slow its decline as a manufacturing base in the $400 billion chip industry. The U.S. company has an existing plant in Ireland and there are older former Advanced Micro Devices Inc. processor factories that are owned by Globalfoundries Inc. in Dresden, Germany. But European manufacturers typically don’t make the kind of advanced logic chips that are regarded as the state of the art in the industry.</p><p><blockquote>对于欧洲来说，此举将减缓其作为4000亿美元芯片行业制造基地的衰落。这家美国公司在爱尔兰有一家现有工厂，在德国德累斯顿还有Globalfoundries Inc.拥有的较老的前Advanced Micro Devices Inc.处理器工厂。但欧洲制造商通常不生产被视为业内最先进的先进逻辑芯片。</blockquote></p><p> NXP Semiconductors NV and STMicroelectronics NV are the continent’s two largest homegrown chipmakers. They focus on parts for cars and other equipment -- rather than the advanced computer processors that are Intel’s specialty.</p><p><blockquote>恩智浦半导体公司和意法半导体公司是非洲大陆最大的两家本土芯片制造商。他们专注于汽车和其他设备的零部件，而不是英特尔擅长的先进计算机处理器。</blockquote></p><p> A global chip shortage also has renewed concerns about the concentration of production in Asia. Manufacturers such as Taiwan Semiconductor Manufacturing Co. and South Korea’s Samsung Electronics Co. have grown increasingly deft at producing chips, forcing Intel to play catch-up. Gelsinger has argued that spreading manufacturing around the world will help avoid the kinds of supply constraints that have hobbled whole industries this year, including automakers.</p><p><blockquote>全球芯片短缺也重新引发了人们对生产集中在亚洲的担忧。台积电公司和三星电子公司等制造商在生产芯片方面越来越熟练，迫使英特尔奋起直追。基辛格认为，将制造业扩展到世界各地将有助于避免今年阻碍包括汽车制造商在内的整个行业的供应限制。</blockquote></p><p> Part of Gelsinger’s plan is to build factories that make chips for other companies, directly rivaling TSMC in the so-called foundry business. Until now, Intel has typically only manufactured chips of its own design.</p><p><blockquote>基辛格计划的一部分是建立为其他公司制造芯片的工厂，在所谓的代工业务上直接与台积电竞争。到目前为止，英特尔通常只制造自己设计的芯片。</blockquote></p><p> To help fund his ambitions, he’s called on lawmakers on both sides of the Atlantic to give public money in the form of tax breaks and grants to chipmakers willing to build plants in Europe and the U.S.</p><p><blockquote>为了资助他的雄心，他呼吁大西洋两岸的立法者以税收减免和拨款的形式向愿意在欧洲和美国建厂的芯片制造商提供公共资金。</blockquote></p><p> By spreading around Intel’s spending, Gelsinger may be trying to placate as many EU members as he can to try to make sure that none of them try to object any central funding that’s made available. But the plans aren’t final yet. The mega-fab will likely be built in Saxony, with German regions of Saxony-Anhalt and Bavaria also in the running for the new factory.</p><p><blockquote>通过分散英特尔的支出，基辛格可能试图安抚尽可能多的欧盟成员国，以确保他们中没有人试图反对任何可用的中央资金。但是计划还没有最终确定。该大型工厂可能会建在萨克森州，德国萨克森-安哈尔特州和巴伐利亚州也在争夺新工厂。</blockquote></p><p> Intel’s ambitious new ventures could bring thousands of jobs. The company is also planning to create 4,000 jobs in Malaysia via a $7.1 billion investment in new chip packaging facilities.</p><p><blockquote>英特尔雄心勃勃的新企业可能会带来数千个就业机会。该公司还计划通过投资71亿美元建设新的芯片封装设施，在马来西亚创造4,000个就业岗位。</blockquote></p><p> Intel’s shares increased 1.2% in early trading Thursday.</p><p><blockquote>英特尔股价周四早盘上涨1.2%。</blockquote></p><p> Even with the potential government help, Intel is budgeting as much as $28 billion for new plants and equipment in 2022, up from roughly $18 billion this year. The spending plans have jarred investors, who worry about the toll on profit. But the massive increase in expenditures will only put Intel on course to keep up with TSMC and Samsung’s spending.</p><p><blockquote>即使有政府的潜在帮助，英特尔2022年的新工厂和设备预算仍高达280亿美元，高于今年的约180亿美元。这些支出计划令投资者感到不安，他们担心利润会受到影响。但支出的大幅增加只会让英特尔跟上台积电和三星的支出。</blockquote></p><p> Shares of Intel, based in Santa Clara, California, have gained just 2.3% this year -- even as its peers have enjoyed boom times. The Philadelphia Stock Exchange Semiconductor Index has climbed 39%, with companies such as Nvidia Corp. more than doubling.</p><p><blockquote>总部位于加利福尼亚州圣克拉拉的英特尔股价今年仅上涨了2.3%，尽管其同行经历了繁荣时期。费城证券交易所半导体指数上涨了39%，英伟达公司等公司的股价上涨了一倍多。</blockquote></p><p> State-of-the art chip production plants cost more than $20 billion, and their most expensive component -- machinery -- is usually obsolete within five years. The German plant could have a price tag in that range. The Italian test and assembly plant, meanwhile, will cost around $10 billion. Intel and government officials there are still negotiating on the site, with Sicily being one area under consideration, according to one of the people familiar with the situation.</p><p><blockquote>最先进的芯片生产厂耗资超过200亿美元，其最昂贵的部件——机械——通常会在五年内过时。德国工厂的价格标签可能在这个范围内。与此同时，意大利测试和装配厂将耗资约100亿美元。据一位知情人士透露，英特尔和那里的政府官员仍在就该地点进行谈判，西西里岛是正在考虑的地区之一。</blockquote></p><p> The French R&amp;D center may be built in either Paris or Grenoble, according to another person. Such facilities typically cost only a fraction of the amount needed to build a factory.</p><p><blockquote>另一位人士称，法国研发中心可能建在巴黎或格勒诺布尔。此类设施的成本通常仅为建造工厂所需费用的一小部分。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/intel-expand-france-germany-italy-091904071.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔"},"source_url":"https://finance.yahoo.com/news/intel-expand-france-germany-italy-091904071.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152565085","content_text":"(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations.\nFrance will be home to a research and design center, and Italy will be the location of a test and assembly factory, according to the people, who asked not to be identified because the plan hasn’t been announced. The main wafer fabrication plant, or fab, will likely be built in Germany, according to the people. Altogether, the expansion will cost tens of billions of dollars.\nChief Executive Officer Pat Gelsinger is trying to restore the world’s largest chipmaker to its former glory. The company has lost its technological edge to rivals and ceded market share -- something the spending binge is meant to address. Gelsinger also wants to bring more production back to the U.S. and Europe, counterbalancing Asia’s manufacturing dominance.\nRepresentatives of the French, German and Italian governments declined to comment, as did Intel spokespeople in Europe and the U.S.\nFor Europe, the move would slow its decline as a manufacturing base in the $400 billion chip industry. The U.S. company has an existing plant in Ireland and there are older former Advanced Micro Devices Inc. processor factories that are owned by Globalfoundries Inc. in Dresden, Germany. But European manufacturers typically don’t make the kind of advanced logic chips that are regarded as the state of the art in the industry.\nNXP Semiconductors NV and STMicroelectronics NV are the continent’s two largest homegrown chipmakers. They focus on parts for cars and other equipment -- rather than the advanced computer processors that are Intel’s specialty.\nA global chip shortage also has renewed concerns about the concentration of production in Asia. Manufacturers such as Taiwan Semiconductor Manufacturing Co. and South Korea’s Samsung Electronics Co. have grown increasingly deft at producing chips, forcing Intel to play catch-up. Gelsinger has argued that spreading manufacturing around the world will help avoid the kinds of supply constraints that have hobbled whole industries this year, including automakers.\nPart of Gelsinger’s plan is to build factories that make chips for other companies, directly rivaling TSMC in the so-called foundry business. Until now, Intel has typically only manufactured chips of its own design.\nTo help fund his ambitions, he’s called on lawmakers on both sides of the Atlantic to give public money in the form of tax breaks and grants to chipmakers willing to build plants in Europe and the U.S.\nBy spreading around Intel’s spending, Gelsinger may be trying to placate as many EU members as he can to try to make sure that none of them try to object any central funding that’s made available. But the plans aren’t final yet. The mega-fab will likely be built in Saxony, with German regions of Saxony-Anhalt and Bavaria also in the running for the new factory.\nIntel’s ambitious new ventures could bring thousands of jobs. The company is also planning to create 4,000 jobs in Malaysia via a $7.1 billion investment in new chip packaging facilities.\nIntel’s shares increased 1.2% in early trading Thursday.\nEven with the potential government help, Intel is budgeting as much as $28 billion for new plants and equipment in 2022, up from roughly $18 billion this year. The spending plans have jarred investors, who worry about the toll on profit. But the massive increase in expenditures will only put Intel on course to keep up with TSMC and Samsung’s spending.\nShares of Intel, based in Santa Clara, California, have gained just 2.3% this year -- even as its peers have enjoyed boom times. The Philadelphia Stock Exchange Semiconductor Index has climbed 39%, with companies such as Nvidia Corp. more than doubling.\nState-of-the art chip production plants cost more than $20 billion, and their most expensive component -- machinery -- is usually obsolete within five years. The German plant could have a price tag in that range. The Italian test and assembly plant, meanwhile, will cost around $10 billion. Intel and government officials there are still negotiating on the site, with Sicily being one area under consideration, according to one of the people familiar with the situation.\nThe French R&D center may be built in either Paris or Grenoble, according to another person. Such facilities typically cost only a fraction of the amount needed to build a factory.","news_type":1,"symbols_score_info":{"INTC":0.9}},"isVote":1,"tweetType":1,"viewCount":2493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698952698,"gmtCreate":1640286479224,"gmtModify":1640286479327,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698952698","repostId":"1122468807","repostType":4,"isVote":1,"tweetType":1,"viewCount":2071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698952835,"gmtCreate":1640286465896,"gmtModify":1640286465896,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698952835","repostId":"1199712599","repostType":4,"repost":{"id":"1199712599","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640269826,"share":"https://www.laohu8.com/m/news/1199712599?lang=zh_CN&edition=full","pubTime":"2021-12-23 22:30","market":"us","language":"en","title":"Stocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199712599","media":"Tiger Newspress","summary":"All three major averages were up Thursday morning, building on back-to-back sessions of gains as fea","content":"<p>All three major averages were up Thursday morning, building on back-to-back sessions of gains as fears the Omicron variant would derail economic growth cooled among investors who sold-off risky assets at the start of the week on reports of swelling case numbers.</p><p><blockquote>周四上午，三大股指均在连续几个交易日上涨的基础上上涨，原因是投资者对奥密克戎变体将破坏经济增长的担忧降温，他们在本周初因病例数量激增而抛售风险资产。</blockquote></p><p> The Nasdaq briefly jumped 180 points, while the Dow Industrial Average and S&amp;P 500 also edged higher.</p><p><blockquote>纳斯达克短暂上涨180点，道琼斯工业平均指数和标普500也小幅走高。</blockquote></p><p> Investors are weighing a trove of economic releases this morning. The Labor Department reported that initial jobless claims&nbsp;totaled 205,000, sustaining a downward trend&nbsp;from the highs of their pandemic peak and reflecting labor market tightness brought on by a demand for workers heading into the new year. The latest print brings the four-week moving average for new claims to its lowest in 52 years, ticking up by 2,750 week-over-week to reach 206,250.</p><p><blockquote>投资者今天上午正在权衡一系列经济数据。美国劳工部报告称，首次申请失业救济人数总计20.5万人，较疫情峰值保持下降趋势，反映出进入新的一年对工人的需求带来的劳动力市场紧张。最新数据显示，新申请失业救济人数的四周移动平均值降至52年来的最低水平，周环比增加2,750人，达到206,250人。</blockquote></p><p> U.S. durable goods orders rose by 2.5% in November, up from the prior month, boosted by a sharp rise in aircraft orders.</p><p><blockquote>受飞机订单大幅上升提振，美国11月耐用品订单环比增长2.5%。</blockquote></p><p> Meanwhile, U.S. consumer prices&nbsp;accelerated at the fastest pace&nbsp;in nearly four decades as shoppers confront rising inflation levels ahead of the holidays.</p><p><blockquote>与此同时，由于购物者在假期前面临通胀水平上升，美国消费者价格以近四十年来最快的速度上涨。</blockquote></p><p> In Wednesday's trading session, investors weighed an upbeat print on consumer confidence levels and the release of an upwardly revised estimate for domestic GDP, placing all three major averages in the green after a mixed open.</p><p><blockquote>在周三的交易时段，投资者权衡了消费者信心水平的乐观情绪和国内GDP预估上调的发布，三大股指在开盘涨跌互现后均呈绿色。</blockquote></p><p> The Conference Board reported consumer confidence&nbsp;increased by a greater-than-expected margin in December,with the headline index at 115.8 during the month and higher than Bloomberg’s consensus estimates of 111.0. In November, the index had a reading of 111.9, revised from an initial report of 109.5. Meanwhile, the nation’s gross domestic product grew at an annual rate of 2.3% in the third quarter in the final estimate from the Bureau of Economic Analysis after the initial report of 2.1%.</p><p><blockquote>世界大型企业联合会报告称，12月份消费者信心增幅超出预期，当月总体指数为115.8，高于彭博社普遍预期的111.0。11月份，该指数读数为111.9，高于最初报告的109.5。与此同时，经济分析局在最初报告为2.1%后，最终估计第三季度美国国内生产总值年增长率为2.3%。</blockquote></p><p> “We’ve been saying that this is definitely a buy the dip sort of market because we expect more earnings upgrades to come,” Anik Sen, PineBridge Investments global head of equities&nbsp;told Yahoo Finance Live. “We think that the real debate should be about the length and strength of the economic cycle ahead.”</p><p><blockquote>PineBridge Investments全球股票主管阿尼克·森(Anik Sen)对雅虎财经直播表示：“我们一直在说，这绝对是一个逢低买入的市场，因为我们预计将出现更多盈利上调。”“我们认为真正的争论应该是关于未来经济周期的长度和强度。”</blockquote></p><p> The clock is also ticking on ayear-end Santa Claus Rally— one in which stocks climb higher in the final seven trading sessions of a year, plus the first two trading days of the new year. Starting tomorrow, traders will see whether 92 years of data uphold.</p><p><blockquote>年终圣诞老人反弹的时间也在流逝——股市在一年的最后七个交易日以及新年的前两个交易日攀升。从明天开始，交易者将看到92年的数据是否成立。</blockquote></p><p> For reasons unclear, over the past 92 years, the S&amp;P 500 gained 77% of the time during the year-end rally period, according to data from Sundial Capital Research. The average gain in this nine-day trading period tallied 2.66%.</p><p><blockquote>Sundial Capital Research的数据显示，出于尚不清楚的原因，在过去92年中，标普500在年终反弹期间有77%的时间上涨。这九天交易期间的平均涨幅为2.66%。</blockquote></p><p> Separately, Oppenheimer chief investment strategistJohn Stoltzfusdisclosedthe most bullish price target on the S&amp;P 500, forecasting a 14% climb to 5,330 by the end of 2022. The 38-year Wall Street veteran’s estimate beats even the most optimistic of his peers, BMO Capital Markets’s Brian Belski, who projected S&amp;P 500 5,300.</p><p><blockquote>另外，Oppenheimer首席投资策略师John Stoltzfus披露了标普500最乐观的目标价，预测到2022年底将上涨14%至5,330点。这位38岁的华尔街资深人士的预测甚至超过了最乐观的同行BMO Capital Markets的Brian Belski，后者预测标普500为5,300点。</blockquote></p><p> Meanwile, Pfizer (PFE)received authorization from the U.S. Food and Drug Administration for its at-home COVID-19 pill&nbsp;following clinical trial data that showed the treatment was 90% effective at preventing hospitalizations and deaths in high-risk patients. Shares of Pfizer gained more than 2% in Wednesday's session following the news and closed up 1.02% at $59.55 a piece.</p><p><blockquote>与此同时，辉瑞（PFE）获得了美国的授权。美国食品药品监督管理局对其家用COVID-19药丸进行了临床试验数据显示，该治疗在预防高危患者住院和死亡方面有90%的有效性。消息传出后，辉瑞股价在周三交易中上涨超过2%，收盘上涨1.02%，至每股59.55美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-23 22:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>All three major averages were up Thursday morning, building on back-to-back sessions of gains as fears the Omicron variant would derail economic growth cooled among investors who sold-off risky assets at the start of the week on reports of swelling case numbers.</p><p><blockquote>周四上午，三大股指均在连续几个交易日上涨的基础上上涨，原因是投资者对奥密克戎变体将破坏经济增长的担忧降温，他们在本周初因病例数量激增而抛售风险资产。</blockquote></p><p> The Nasdaq briefly jumped 180 points, while the Dow Industrial Average and S&amp;P 500 also edged higher.</p><p><blockquote>纳斯达克短暂上涨180点，道琼斯工业平均指数和标普500也小幅走高。</blockquote></p><p> Investors are weighing a trove of economic releases this morning. The Labor Department reported that initial jobless claims&nbsp;totaled 205,000, sustaining a downward trend&nbsp;from the highs of their pandemic peak and reflecting labor market tightness brought on by a demand for workers heading into the new year. The latest print brings the four-week moving average for new claims to its lowest in 52 years, ticking up by 2,750 week-over-week to reach 206,250.</p><p><blockquote>投资者今天上午正在权衡一系列经济数据。美国劳工部报告称，首次申请失业救济人数总计20.5万人，较疫情峰值保持下降趋势，反映出进入新的一年对工人的需求带来的劳动力市场紧张。最新数据显示，新申请失业救济人数的四周移动平均值降至52年来的最低水平，周环比增加2,750人，达到206,250人。</blockquote></p><p> U.S. durable goods orders rose by 2.5% in November, up from the prior month, boosted by a sharp rise in aircraft orders.</p><p><blockquote>受飞机订单大幅上升提振，美国11月耐用品订单环比增长2.5%。</blockquote></p><p> Meanwhile, U.S. consumer prices&nbsp;accelerated at the fastest pace&nbsp;in nearly four decades as shoppers confront rising inflation levels ahead of the holidays.</p><p><blockquote>与此同时，由于购物者在假期前面临通胀水平上升，美国消费者价格以近四十年来最快的速度上涨。</blockquote></p><p> In Wednesday's trading session, investors weighed an upbeat print on consumer confidence levels and the release of an upwardly revised estimate for domestic GDP, placing all three major averages in the green after a mixed open.</p><p><blockquote>在周三的交易时段，投资者权衡了消费者信心水平的乐观情绪和国内GDP预估上调的发布，三大股指在开盘涨跌互现后均呈绿色。</blockquote></p><p> The Conference Board reported consumer confidence&nbsp;increased by a greater-than-expected margin in December,with the headline index at 115.8 during the month and higher than Bloomberg’s consensus estimates of 111.0. In November, the index had a reading of 111.9, revised from an initial report of 109.5. Meanwhile, the nation’s gross domestic product grew at an annual rate of 2.3% in the third quarter in the final estimate from the Bureau of Economic Analysis after the initial report of 2.1%.</p><p><blockquote>世界大型企业联合会报告称，12月份消费者信心增幅超出预期，当月总体指数为115.8，高于彭博社普遍预期的111.0。11月份，该指数读数为111.9，高于最初报告的109.5。与此同时，经济分析局在最初报告为2.1%后，最终估计第三季度美国国内生产总值年增长率为2.3%。</blockquote></p><p> “We’ve been saying that this is definitely a buy the dip sort of market because we expect more earnings upgrades to come,” Anik Sen, PineBridge Investments global head of equities&nbsp;told Yahoo Finance Live. “We think that the real debate should be about the length and strength of the economic cycle ahead.”</p><p><blockquote>PineBridge Investments全球股票主管阿尼克·森(Anik Sen)对雅虎财经直播表示：“我们一直在说，这绝对是一个逢低买入的市场，因为我们预计将出现更多盈利上调。”“我们认为真正的争论应该是关于未来经济周期的长度和强度。”</blockquote></p><p> The clock is also ticking on ayear-end Santa Claus Rally— one in which stocks climb higher in the final seven trading sessions of a year, plus the first two trading days of the new year. Starting tomorrow, traders will see whether 92 years of data uphold.</p><p><blockquote>年终圣诞老人反弹的时间也在流逝——股市在一年的最后七个交易日以及新年的前两个交易日攀升。从明天开始，交易者将看到92年的数据是否成立。</blockquote></p><p> For reasons unclear, over the past 92 years, the S&amp;P 500 gained 77% of the time during the year-end rally period, according to data from Sundial Capital Research. The average gain in this nine-day trading period tallied 2.66%.</p><p><blockquote>Sundial Capital Research的数据显示，出于尚不清楚的原因，在过去92年中，标普500在年终反弹期间有77%的时间上涨。这九天交易期间的平均涨幅为2.66%。</blockquote></p><p> Separately, Oppenheimer chief investment strategistJohn Stoltzfusdisclosedthe most bullish price target on the S&amp;P 500, forecasting a 14% climb to 5,330 by the end of 2022. The 38-year Wall Street veteran’s estimate beats even the most optimistic of his peers, BMO Capital Markets’s Brian Belski, who projected S&amp;P 500 5,300.</p><p><blockquote>另外，Oppenheimer首席投资策略师John Stoltzfus披露了标普500最乐观的目标价，预测到2022年底将上涨14%至5,330点。这位38岁的华尔街资深人士的预测甚至超过了最乐观的同行BMO Capital Markets的Brian Belski，后者预测标普500为5,300点。</blockquote></p><p> Meanwile, Pfizer (PFE)received authorization from the U.S. Food and Drug Administration for its at-home COVID-19 pill&nbsp;following clinical trial data that showed the treatment was 90% effective at preventing hospitalizations and deaths in high-risk patients. Shares of Pfizer gained more than 2% in Wednesday's session following the news and closed up 1.02% at $59.55 a piece.</p><p><blockquote>与此同时，辉瑞（PFE）获得了美国的授权。美国食品药品监督管理局对其家用COVID-19药丸进行了临床试验数据显示，该治疗在预防高危患者住院和死亡方面有90%的有效性。消息传出后，辉瑞股价在周三交易中上涨超过2%，收盘上涨1.02%，至每股59.55美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199712599","content_text":"All three major averages were up Thursday morning, building on back-to-back sessions of gains as fears the Omicron variant would derail economic growth cooled among investors who sold-off risky assets at the start of the week on reports of swelling case numbers.\nThe Nasdaq briefly jumped 180 points, while the Dow Industrial Average and S&P 500 also edged higher.\nInvestors are weighing a trove of economic releases this morning. The Labor Department reported that initial jobless claims totaled 205,000, sustaining a downward trend from the highs of their pandemic peak and reflecting labor market tightness brought on by a demand for workers heading into the new year. The latest print brings the four-week moving average for new claims to its lowest in 52 years, ticking up by 2,750 week-over-week to reach 206,250.\nU.S. durable goods orders rose by 2.5% in November, up from the prior month, boosted by a sharp rise in aircraft orders.\nMeanwhile, U.S. consumer prices accelerated at the fastest pace in nearly four decades as shoppers confront rising inflation levels ahead of the holidays.\nIn Wednesday's trading session, investors weighed an upbeat print on consumer confidence levels and the release of an upwardly revised estimate for domestic GDP, placing all three major averages in the green after a mixed open.\nThe Conference Board reported consumer confidence increased by a greater-than-expected margin in December,with the headline index at 115.8 during the month and higher than Bloomberg’s consensus estimates of 111.0. In November, the index had a reading of 111.9, revised from an initial report of 109.5. Meanwhile, the nation’s gross domestic product grew at an annual rate of 2.3% in the third quarter in the final estimate from the Bureau of Economic Analysis after the initial report of 2.1%.\n“We’ve been saying that this is definitely a buy the dip sort of market because we expect more earnings upgrades to come,” Anik Sen, PineBridge Investments global head of equities told Yahoo Finance Live. “We think that the real debate should be about the length and strength of the economic cycle ahead.”\nThe clock is also ticking on ayear-end Santa Claus Rally— one in which stocks climb higher in the final seven trading sessions of a year, plus the first two trading days of the new year. Starting tomorrow, traders will see whether 92 years of data uphold.\nFor reasons unclear, over the past 92 years, the S&P 500 gained 77% of the time during the year-end rally period, according to data from Sundial Capital Research. The average gain in this nine-day trading period tallied 2.66%.\nSeparately, Oppenheimer chief investment strategistJohn Stoltzfusdisclosedthe most bullish price target on the S&P 500, forecasting a 14% climb to 5,330 by the end of 2022. The 38-year Wall Street veteran’s estimate beats even the most optimistic of his peers, BMO Capital Markets’s Brian Belski, who projected S&P 500 5,300.\nMeanwile, Pfizer (PFE)received authorization from the U.S. Food and Drug Administration for its at-home COVID-19 pill following clinical trial data that showed the treatment was 90% effective at preventing hospitalizations and deaths in high-risk patients. Shares of Pfizer gained more than 2% in Wednesday's session following the news and closed up 1.02% at $59.55 a piece.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":3702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690152971,"gmtCreate":1639648896720,"gmtModify":1639648910879,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690152971","repostId":"607301269","repostType":1,"repost":{"id":607301269,"gmtCreate":1639483841813,"gmtModify":1639548621206,"author":{"id":"3558937605407666","authorId":"3558937605407666","name":"46d9935c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558937605407666","idStr":"3558937605407666"},"themes":[],"title":"2021年迄今录得机构净流入最高的20只股票回报率为32%","htmlText":"本文章是新加坡交易所官方文章关于机构投资新加坡蓝筹股[财迷]&nbsp; 2021年截至12月3日，录得机构净流入最高的20只股票的净买入总计为28亿新元，过去48周内的平均总回报率为32%，其中，有17只股票超过海峡时报指数13%的总回报率，19只股票超过富时亚太指数3%的总回报率。 在这20只股票28亿新元的净买入中，超过4亿新元是自9月30日以来录得，其中，有11只股票在过去九周内录得机构净流入，大华银行、星展银行和永科领涨其他股票。12月3日，永科创下5.29新元的新高，这使得其2021年截至12月3日的总回报率达到55%。 这20只股票涵盖过去48周内全球股票行业中表现较为强劲的部分行业，如银行、工业类REIT、农业和半导体，此外，还包括报业控股、胜科工业和凯德投资公司等一年来持续进行战略重组的股票。 2020年底收于近2,850点后，海峡时报指数全年呈上升趋势，在11月26日出现的Omicron变异毒株给全球股票基准带来冲击之前，于11月9日创下超过3,250的高点，这使得海峡时报指数达到目前接近3,100点的水平。海指今年录得13%的总回报率，而富时亚太指数的总回报率则为3%。2021年截至12月3日，超过300只新加坡上市股票录得机构净流入。过去48周内录得机构净买入最高的20只股票占这300只股票机构净流入总额的75%，星展银行、大华银行和报业控股领涨这20只股票。上述20只股票在过去48周内的平均总回报率为32%，其中，有17只股票超过海峡时报指数13%的总回报率，19只股票超过富时亚太指数3%的总回报率。这20只股票及它们在2021年截至12月3日的机构净流入（自9月30日以来的机构净流入/流出除外）如下表所示。<a target=\"_blank\" href=\"https://laohu8.com/S/D05.SI\">$星展集团控股(D05.SI)$&lt;</a>","listText":"本文章是新加坡交易所官方文章关于机构投资新加坡蓝筹股[财迷]&nbsp; 2021年截至12月3日，录得机构净流入最高的20只股票的净买入总计为28亿新元，过去48周内的平均总回报率为32%，其中，有17只股票超过海峡时报指数13%的总回报率，19只股票超过富时亚太指数3%的总回报率。 在这20只股票28亿新元的净买入中，超过4亿新元是自9月30日以来录得，其中，有11只股票在过去九周内录得机构净流入，大华银行、星展银行和永科领涨其他股票。12月3日，永科创下5.29新元的新高，这使得其2021年截至12月3日的总回报率达到55%。 这20只股票涵盖过去48周内全球股票行业中表现较为强劲的部分行业，如银行、工业类REIT、农业和半导体，此外，还包括报业控股、胜科工业和凯德投资公司等一年来持续进行战略重组的股票。 2020年底收于近2,850点后，海峡时报指数全年呈上升趋势，在11月26日出现的Omicron变异毒株给全球股票基准带来冲击之前，于11月9日创下超过3,250的高点，这使得海峡时报指数达到目前接近3,100点的水平。海指今年录得13%的总回报率，而富时亚太指数的总回报率则为3%。2021年截至12月3日，超过300只新加坡上市股票录得机构净流入。过去48周内录得机构净买入最高的20只股票占这300只股票机构净流入总额的75%，星展银行、大华银行和报业控股领涨这20只股票。上述20只股票在过去48周内的平均总回报率为32%，其中，有17只股票超过海峡时报指数13%的总回报率，19只股票超过富时亚太指数3%的总回报率。这20只股票及它们在2021年截至12月3日的机构净流入（自9月30日以来的机构净流入/流出除外）如下表所示。<a target=\"_blank\" href=\"https://laohu8.com/S/D05.SI\">$星展集团控股(D05.SI)$&lt;</a>","text":"本文章是新加坡交易所官方文章关于机构投资新加坡蓝筹股[财迷] 2021年截至12月3日，录得机构净流入最高的20只股票的净买入总计为28亿新元，过去48周内的平均总回报率为32%，其中，有17只股票超过海峡时报指数13%的总回报率，19只股票超过富时亚太指数3%的总回报率。 在这20只股票28亿新元的净买入中，超过4亿新元是自9月30日以来录得，其中，有11只股票在过去九周内录得机构净流入，大华银行、星展银行和永科领涨其他股票。12月3日，永科创下5.29新元的新高，这使得其2021年截至12月3日的总回报率达到55%。 这20只股票涵盖过去48周内全球股票行业中表现较为强劲的部分行业，如银行、工业类REIT、农业和半导体，此外，还包括报业控股、胜科工业和凯德投资公司等一年来持续进行战略重组的股票。 2020年底收于近2,850点后，海峡时报指数全年呈上升趋势，在11月26日出现的Omicron变异毒株给全球股票基准带来冲击之前，于11月9日创下超过3,250的高点，这使得海峡时报指数达到目前接近3,100点的水平。海指今年录得13%的总回报率，而富时亚太指数的总回报率则为3%。2021年截至12月3日，超过300只新加坡上市股票录得机构净流入。过去48周内录得机构净买入最高的20只股票占这300只股票机构净流入总额的75%，星展银行、大华银行和报业控股领涨这20只股票。上述20只股票在过去48周内的平均总回报率为32%，其中，有17只股票超过海峡时报指数13%的总回报率，19只股票超过富时亚太指数3%的总回报率。这20只股票及它们在2021年截至12月3日的机构净流入（自9月30日以来的机构净流入/流出除外）如下表所示。$星展集团控股(D05.SI)$<","images":[{"img":"https://static.tigerbbs.com/3a5aa837cdedb0dc52e1e45932e716e7","width":"688","height":"486"},{"img":"https://static.tigerbbs.com/e9724155d0def0ecd2771be6d26cc595","width":"688","height":"605"},{"img":"https://static.tigerbbs.com/c2a7b421a702a2d30d42bf04035cf1f9","width":"688","height":"405"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607301269","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843011905,"gmtCreate":1635781895489,"gmtModify":1635781895489,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Share","listText":"Share","text":"Share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843011905","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843019521,"gmtCreate":1635781837737,"gmtModify":1635781837737,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Share","listText":"Share","text":"Share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843019521","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3455,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":166139318,"gmtCreate":1623995422434,"gmtModify":1634024386945,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166139318","repostId":"2144742925","repostType":4,"isVote":1,"tweetType":1,"viewCount":2670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166130611,"gmtCreate":1623995387333,"gmtModify":1634024387543,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/166130611","repostId":"1175693382","repostType":4,"repost":{"id":"1175693382","kind":"news","pubTimestamp":1623978463,"share":"https://www.laohu8.com/m/news/1175693382?lang=zh_CN&edition=full","pubTime":"2021-06-18 09:07","market":"us","language":"en","title":"Alibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1175693382","media":"seekingalpha","summary":"Alibaba is probably the most undervalued growth stock right now.The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.The short term technical picture may be turning bullish with a potential double bottom price action signal.When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the ","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Alibaba is probably the most undervalued growth stock right now.</li>  <li>The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.</li>  <li>The short term technical picture may be turning bullish with a potential double bottom price action signal.</li>  <li>We discuss the company’s multiple growth drivers and let investors judge for themselves.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/05e63c77d4f3f3dc3d618e43044638bb\" tg-width=\"768\" tg-height=\"512\"><span>Yongyuan Dai/iStock Unreleased via Getty Images</span></p><p><blockquote><ul><li>阿里巴巴-SW可能是目前最被低估的成长型股票。</li><li>该公司在快速扩张的市场中的多种增长动力使其估值看起来更加令人困惑。</li><li>短期技术面可能会转向看涨，并出现潜在的双底价格走势信号。</li><li>我们讨论公司的多种增长动力，让投资者自行判断。</li></ul><p class=\"t-img-caption\"><span>戴永源/iStock未通过Getty Images发布</span></p></blockquote></p><p> <b>The Technical Thesis</b></p><p><blockquote><b>技术论文</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7febf6ed056b0e3bc038321cdaad9b1c\" tg-width=\"1280\" tg-height=\"782\"><span>Source: TradingView</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView</span></p></blockquote></p><p> Alibaba’s&nbsp;stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.</p><p><blockquote>自11月20日早些时候蚂蚁金服IPO被取消以来，阿里巴巴-SW的股价已经经历了可怕的8个月，股价低迷，较高点下跌了34%。当考虑其长期上升趋势的健康状况时，很明显BABA具有相对较强的上升趋势偏差，并且通常在其关键的50W MA上得到良好支撑。过去4年中唯一一次失去关键的50W MA支撑位是在2018年熊市期间，当时BABA下跌了约40%，但仍在重要的200W MA上方得到良好支撑，我们通常认为这是“最后一道防线”。现在阿里巴巴再次面临类似的情况：下跌34%，失去了50W MA，但看起来在200W MA上方得到了很好的支撑。除此之外，价格行为分析中的一个有趣观察可能会导致价格行为交易者/投资者特别看涨：潜在的双底形成。阿里巴巴的价格似乎正在经历双底，就像2018年熊市期间一样，随后强劲反弹。因此，阿里巴巴目前的水平现在可能提供一个可能的技术买入切入点。</blockquote></p><p> <b>BABA's Fundamental Thesis: Rapidly Expanding Growth Drivers</b></p><p><blockquote><b>阿里巴巴的基本论点：快速扩大增长动力</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eba49f5881708929949c30628eedc5d4\" tg-width=\"934\" tg-height=\"578\"><span>Annual GMV. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年度GMV。数据来源：公司备案</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4d6c4ed3e2402f5af52b2dea8bab411\" tg-width=\"836\" tg-height=\"517\"><span>Annual e-commerce revenue. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年电子商务收入。数据来源：公司备案</span></p></blockquote></p><p> BABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.</p><p><blockquote>阿里巴巴的GMV在短短7年内从1.68 T元增长到7.49 T元，复合年增长率为23.8%，增速确实惊人。我们还看到其GMV增长转化为收入增长，其中国商业收入从76.7亿元增长至4736.8亿元，过去10年复合年增长率为51%。虽然其国际足迹仍然相当小，但在过去10年中，其复合年增长率仍为30.42%，这一点也不慢。</blockquote></p><p> Even though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.</p><p><blockquote>尽管预计未来三年中国电子商务市场的增长速度将大幅放缓，复合年增长率为12.4%，从2021年的13.8 T元（相当于2.16 T美元）增长到2024年的19.6 T元（相当于3.06 T美元），但庞大的市场规模仍然为阿里巴巴及其最接近的竞争对手提供了巨大的增长潜力。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffe2dee43f267e1d1399c68e3ca60f36\" tg-width=\"600\" tg-height=\"371\"><span>E-commerce revenue in the U.S. Data source: Statista</span></p><p><blockquote><p class=\"t-img-caption\"><span>美国电子商务收入数据来源：Statista</span></p></blockquote></p><p> When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.</p><p><blockquote>当我们通过比较中国与美国电子商务市场的增长率和规模来更清晰地看待事物时，我们可以看到它们的规模和增长率的巨大差异，因为美国电子商务市场预计仅增长2021年至2025年的复合年增长率为4.67%，明显低于中国的12.4%。此外，美国市场的总收入预计也将达到约5630亿美元，是届时中国市场预计价值的18%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d5a8d0d8a6a2dcdf667a6f33c6c9771\" tg-width=\"1280\" tg-height=\"702\"><span>Peers EBIT Margin and Projected EBIT Margin. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行息税前利润率和预计息税前利润率。数据来源：标普资本智商</span></p></blockquote></p><p> Even though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&amp;A, and therefore skewed its EBIT margin to the downside.</p><p><blockquote>尽管阿里巴巴-SW一直面临着来自快速增长的主要竞争对手京东（纳斯达克：JD）和拼多多（纳斯达克：PDD）的越来越大的竞争压力，但阿里巴巴已经在经营利润更高的业务（息税前利润和自由现金流），并且预计未来将继续实现强劲的盈利能力，这将使该公司具有巨大的灵活性，可以与京东和拼多多正面竞争，以扩大其领导地位。投资者可能会注意到，阿里巴巴的息税前利润率受到其SG&amp;A中反映的27.82亿美元一次性行政罚款的影响，因此其息税前利润率出现下行。</blockquote></p><p></p><p> One important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of&nbsp;823M AAC&nbsp;in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only&nbsp;100M AAC in Q2’C17&nbsp;as compared to BABA’s 466M AAC in the same period.</p><p><blockquote>一项重要举措是该公司决定进一步投资社区市场，这是拼多多的主要电子商务战略，拼多多在最近一个季度总共获得了8.23亿AAC，而阿里巴巴的AAC为8.91亿。与阿里巴巴同期的4.66亿AAC相比，拼多多的AAC在2017年第二季度仅有1亿AAC，其AAC增长确实是惊人的。</blockquote></p><p> Therefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.</p><p><blockquote>因此，增长势头肯定已经转向社区市场领域，阿里巴巴需要拿出重磅炸弹（它已经拥有）来与拼多多和京东争夺主导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b83b69b08b1f4b11a26393c8e6eead5\" tg-width=\"600\" tg-height=\"371\"><span>Market size of community group buying in China. Data source: iiMedia Research</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国社区团购的市场规模。数据来源：艾媒咨询</span></p></blockquote></p><p> Even though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.</p><p><blockquote>尽管预计到2022年1020亿元的总市场规模仅占阿里巴巴21财年中国商业收入的21.5%左右，但阿里巴巴不能错过2019年至2022年3年内44.22%的预期快速复合年增长率。虽然市场还比较小，但BABA不能让这个市场目前的龙头：PDD在旁人无知的情况下，如此轻易地称霸并吞噬早期的高增长率。当然，阿里巴巴必须竞争并争取自己在这一领域的地位，并争取早期领导地位，以防止拼多多扩大领先优势。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b97b2b4a8a182dc9846d8fb7e4039877\" tg-width=\"1280\" tg-height=\"770\"><span>PDD profitability metrics &amp; revenue growth forecast. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>PDD盈利指标和收入增长预测。数据来源：标普资本智商</span></p></blockquote></p><p> We could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.</p><p><blockquote>我们可以从上图中观察到，拼多多的收入预计将在未来几年继续快速增长，尽管预计随后将正常化。更重要的是，拼多多预计未来的息税前利润和自由现金流盈利能力也将日益提高。这表明，社区市场细分市场是一个非常重要的增长动力，阿里巴巴必须利用其优势来利用它，以否认拼多多在游戏早期声称的无可争议的领导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3aadc32155b4108426a1a982e3b5b1c2\" tg-width=\"640\" tg-height=\"360\"><span>China public cloud spending. Source:China Internet Watch; Canalys</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云支出。来源：中国互联网观察；Canalys</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c1538b9f7bdc8d6d35a72d9acf8ecbc\" tg-width=\"600\" tg-height=\"371\"><span>Size of China public cloud market. Data source: CAICT; Sina.com.cn</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云市场规模。数据来源：中国信通技术；新浪网</span></p></blockquote></p><p> BABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.</p><p><blockquote>阿里巴巴在中国公有云市场拥有40%的份额，远远领先于其主要竞争对手。然而，值得注意的是，尽管处于领先地位，阿里巴巴仍处于大力投资模式，以继续扩大其市场份额，因为中国公共云市场预计将从2017年的264.8亿元增长到2023年的2307.4亿元，这将代表CAGR 43.4%，这是一个令人难以置信的出色增长率。当我们将中国的增长率与全球增长率（见下文）进行比较时，这一点尤其明显，因为全球公共云支出预计将从2017年的1450亿美元增长到2022年的3970亿美元，这将代表22.3%的CAGR。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/06198c569504bc303c34563041dfb294\" tg-width=\"600\" tg-height=\"371\"><span>Worldwide public cloud spending. Data source: Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云支出。数据来源：Gartner</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8482037f60575f964053ab732496bee3\" tg-width=\"1176\" tg-height=\"700\"><span>Worldwide public cloud market share. Source:CnTechPost; Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云市场份额。来源：CnTechPost；Gartner</span></p></blockquote></p><p> Therefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.</p><p><blockquote>因此，阿里云在2020年以9.5%的市场份额继续扩大对Alphabet（纳斯达克：GOOGL）（纳斯达克：GOOG）GCP的领先优势，我并不觉得奇怪。虽然亚马逊仍然是市场上明显的领导者，但随着公共云支出的持续扩大，其市场份额一直在大幅下降，这表明多个参与者存在巨大的增长潜力。凭借阿里巴巴在快速扩张的中国市场的领导地位，我越来越看好该细分市场未来的利润和自由现金流对阿里巴巴业绩的贡献。尽管阿里巴巴的云部门尚未实现息税前利润（21财年息税前利润率：-15%，20财年息税前利润率：-17.5%），但值得注意的是，Alphabet的GCP也尚未实现盈利（20财年息税前利润率：-42.9%，19财年息税前利润率：-52%）。因此，我们需要给阿里巴巴一些时间来扩大其在亚太地区和中国的云服务规模，预计阿里巴巴将拥有更强大的领导力，使其能够更快地增长，投资者应该预计随着时间的推移，这将是一个高利润的细分市场。</blockquote></p><p> <b>BABA's Valuations Look Highly Compelling</b></p><p><blockquote><b>阿里巴巴的估值看起来非常引人注目</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62a087c4b3ef7efc2c5dde813e3b959d\" tg-width=\"1000\" tg-height=\"600\"><span>NTM TEV / EBIT 3Y range.</span></p><p><blockquote><p class=\"t-img-caption\"><span>NTM TEV/EBIT 3Y范围。</span></p></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2605c0e5ad364a7a43929fef204595c\" tg-width=\"1280\" tg-height=\"687\"><span>EV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>EV/Fwd息税前利润和EV/Fwd Rev趋势。数据来源：标普资本智商</span></p></blockquote></p><p> When we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.</p><p><blockquote>当我们考虑阿里巴巴的TEV/EBIT历史范围（3年平均值为33.54倍）时，阿里巴巴的EV/Fwd EBIT趋势无疑意味着该股票被严重低估，因为预计阿里巴巴的收入和营业利润仍将快速增长。然而，由于我们希望更清楚地了解其同行的估值情况，我们认为如果我们对阿里巴巴的息税前利润进行估值，而不是下面介绍的一组基准公司，这将是有用的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d27873e676dfb23c98d4a69aa5861e02\" tg-width=\"1280\" tg-height=\"1117\"><span>Peers EV / EBIT Valuations. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行EV/EBIT估值。数据来源：标普资本智商</span></p></blockquote></p><p> By using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.</p><p><blockquote>通过混合使用历史和远期息税前利润，我们可以看到，与基准公司一组观察值的中值相比，阿里巴巴的EV/EBIT看起来确实被低估了。我们得出阿里巴巴的公允价值范围为294.98美元，位于该范围的中点，基于当前210美元的股价，这意味着40.5%的潜在上涨空间。</blockquote></p><p> <b>Risks to Assumptions</b></p><p><blockquote><b>假设风险</b></blockquote></p><p> Now, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.</p><p><blockquote>现在，看着先生如何表现显然令人困惑。市场决定对阿里巴巴进行折扣，就好像该公司已经失去了所有关键的增长来源，而事实上，其商业部门、新的市场举措和不断增长的阿里云部门仍有很大的潜在上涨空间，其中。我们认为该股表现不佳的主要现实原因只是监管风险。我们认为投资者应该承认这种风险是非常真实的，有时大型中国公司会发现自己受到中国政府的额外审查（事实上这并不是什么新鲜事）。这里关键的是，中国政府似乎对其科技巨头的行为和行动拥有重大影响力，而这些影响力有时可能在很大程度上是不可预测的。市场当然讨厌不可预测性，因此他们可能会因此大幅折扣阿里巴巴。如果投资者无法应对潜在不可预测的监管行动及其后果的不确定性，那么阿里巴巴可能不适合您。然而，如果你认为这只是阿里巴巴漫长旅程中的一个短暂时刻，那么你肯定会发现阿里巴巴现在的估值极具吸引力，再加上长期思维。</blockquote></p><p> <b>Wrapping It All Up</b></p><p><blockquote><b>把这一切包起来</b></blockquote></p><p> Alibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.</p><p><blockquote>阿里巴巴-SW继续取得稳健的业绩，展示了公司强大的执行能力。由于该公司继续在一个拥有如此多增长动力的市场中运营，预计将推动公司未来的增长，投资者应该会发现当前的估值非常有吸引力。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2021-06-18 09:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Alibaba is probably the most undervalued growth stock right now.</li>  <li>The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.</li>  <li>The short term technical picture may be turning bullish with a potential double bottom price action signal.</li>  <li>We discuss the company’s multiple growth drivers and let investors judge for themselves.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/05e63c77d4f3f3dc3d618e43044638bb\" tg-width=\"768\" tg-height=\"512\"><span>Yongyuan Dai/iStock Unreleased via Getty Images</span></p><p><blockquote><ul><li>阿里巴巴-SW可能是目前最被低估的成长型股票。</li><li>该公司在快速扩张的市场中的多种增长动力使其估值看起来更加令人困惑。</li><li>短期技术面可能会转向看涨，并出现潜在的双底价格走势信号。</li><li>我们讨论公司的多种增长动力，让投资者自行判断。</li></ul><p class=\"t-img-caption\"><span>戴永源/iStock未通过Getty Images发布</span></p></blockquote></p><p> <b>The Technical Thesis</b></p><p><blockquote><b>技术论文</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7febf6ed056b0e3bc038321cdaad9b1c\" tg-width=\"1280\" tg-height=\"782\"><span>Source: TradingView</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView</span></p></blockquote></p><p> Alibaba’s&nbsp;stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.</p><p><blockquote>自11月20日早些时候蚂蚁金服IPO被取消以来，阿里巴巴-SW的股价已经经历了可怕的8个月，股价低迷，较高点下跌了34%。当考虑其长期上升趋势的健康状况时，很明显BABA具有相对较强的上升趋势偏差，并且通常在其关键的50W MA上得到良好支撑。过去4年中唯一一次失去关键的50W MA支撑位是在2018年熊市期间，当时BABA下跌了约40%，但仍在重要的200W MA上方得到良好支撑，我们通常认为这是“最后一道防线”。现在阿里巴巴再次面临类似的情况：下跌34%，失去了50W MA，但看起来在200W MA上方得到了很好的支撑。除此之外，价格行为分析中的一个有趣观察可能会导致价格行为交易者/投资者特别看涨：潜在的双底形成。阿里巴巴的价格似乎正在经历双底，就像2018年熊市期间一样，随后强劲反弹。因此，阿里巴巴目前的水平现在可能提供一个可能的技术买入切入点。</blockquote></p><p> <b>BABA's Fundamental Thesis: Rapidly Expanding Growth Drivers</b></p><p><blockquote><b>阿里巴巴的基本论点：快速扩大增长动力</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eba49f5881708929949c30628eedc5d4\" tg-width=\"934\" tg-height=\"578\"><span>Annual GMV. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年度GMV。数据来源：公司备案</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4d6c4ed3e2402f5af52b2dea8bab411\" tg-width=\"836\" tg-height=\"517\"><span>Annual e-commerce revenue. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年电子商务收入。数据来源：公司备案</span></p></blockquote></p><p> BABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.</p><p><blockquote>阿里巴巴的GMV在短短7年内从1.68 T元增长到7.49 T元，复合年增长率为23.8%，增速确实惊人。我们还看到其GMV增长转化为收入增长，其中国商业收入从76.7亿元增长至4736.8亿元，过去10年复合年增长率为51%。虽然其国际足迹仍然相当小，但在过去10年中，其复合年增长率仍为30.42%，这一点也不慢。</blockquote></p><p> Even though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.</p><p><blockquote>尽管预计未来三年中国电子商务市场的增长速度将大幅放缓，复合年增长率为12.4%，从2021年的13.8 T元（相当于2.16 T美元）增长到2024年的19.6 T元（相当于3.06 T美元），但庞大的市场规模仍然为阿里巴巴及其最接近的竞争对手提供了巨大的增长潜力。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffe2dee43f267e1d1399c68e3ca60f36\" tg-width=\"600\" tg-height=\"371\"><span>E-commerce revenue in the U.S. Data source: Statista</span></p><p><blockquote><p class=\"t-img-caption\"><span>美国电子商务收入数据来源：Statista</span></p></blockquote></p><p> When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.</p><p><blockquote>当我们通过比较中国与美国电子商务市场的增长率和规模来更清晰地看待事物时，我们可以看到它们的规模和增长率的巨大差异，因为美国电子商务市场预计仅增长2021年至2025年的复合年增长率为4.67%，明显低于中国的12.4%。此外，美国市场的总收入预计也将达到约5630亿美元，是届时中国市场预计价值的18%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d5a8d0d8a6a2dcdf667a6f33c6c9771\" tg-width=\"1280\" tg-height=\"702\"><span>Peers EBIT Margin and Projected EBIT Margin. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行息税前利润率和预计息税前利润率。数据来源：标普资本智商</span></p></blockquote></p><p> Even though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&amp;A, and therefore skewed its EBIT margin to the downside.</p><p><blockquote>尽管阿里巴巴-SW一直面临着来自快速增长的主要竞争对手京东（纳斯达克：JD）和拼多多（纳斯达克：PDD）的越来越大的竞争压力，但阿里巴巴已经在经营利润更高的业务（息税前利润和自由现金流），并且预计未来将继续实现强劲的盈利能力，这将使该公司具有巨大的灵活性，可以与京东和拼多多正面竞争，以扩大其领导地位。投资者可能会注意到，阿里巴巴的息税前利润率受到其SG&amp;A中反映的27.82亿美元一次性行政罚款的影响，因此其息税前利润率出现下行。</blockquote></p><p></p><p> One important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of&nbsp;823M AAC&nbsp;in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only&nbsp;100M AAC in Q2’C17&nbsp;as compared to BABA’s 466M AAC in the same period.</p><p><blockquote>一项重要举措是该公司决定进一步投资社区市场，这是拼多多的主要电子商务战略，拼多多在最近一个季度总共获得了8.23亿AAC，而阿里巴巴的AAC为8.91亿。与阿里巴巴同期的4.66亿AAC相比，拼多多的AAC在2017年第二季度仅有1亿AAC，其AAC增长确实是惊人的。</blockquote></p><p> Therefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.</p><p><blockquote>因此，增长势头肯定已经转向社区市场领域，阿里巴巴需要拿出重磅炸弹（它已经拥有）来与拼多多和京东争夺主导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b83b69b08b1f4b11a26393c8e6eead5\" tg-width=\"600\" tg-height=\"371\"><span>Market size of community group buying in China. Data source: iiMedia Research</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国社区团购的市场规模。数据来源：艾媒咨询</span></p></blockquote></p><p> Even though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.</p><p><blockquote>尽管预计到2022年1020亿元的总市场规模仅占阿里巴巴21财年中国商业收入的21.5%左右，但阿里巴巴不能错过2019年至2022年3年内44.22%的预期快速复合年增长率。虽然市场还比较小，但BABA不能让这个市场目前的龙头：PDD在旁人无知的情况下，如此轻易地称霸并吞噬早期的高增长率。当然，阿里巴巴必须竞争并争取自己在这一领域的地位，并争取早期领导地位，以防止拼多多扩大领先优势。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b97b2b4a8a182dc9846d8fb7e4039877\" tg-width=\"1280\" tg-height=\"770\"><span>PDD profitability metrics &amp; revenue growth forecast. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>PDD盈利指标和收入增长预测。数据来源：标普资本智商</span></p></blockquote></p><p> We could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.</p><p><blockquote>我们可以从上图中观察到，拼多多的收入预计将在未来几年继续快速增长，尽管预计随后将正常化。更重要的是，拼多多预计未来的息税前利润和自由现金流盈利能力也将日益提高。这表明，社区市场细分市场是一个非常重要的增长动力，阿里巴巴必须利用其优势来利用它，以否认拼多多在游戏早期声称的无可争议的领导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3aadc32155b4108426a1a982e3b5b1c2\" tg-width=\"640\" tg-height=\"360\"><span>China public cloud spending. Source:China Internet Watch; Canalys</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云支出。来源：中国互联网观察；Canalys</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c1538b9f7bdc8d6d35a72d9acf8ecbc\" tg-width=\"600\" tg-height=\"371\"><span>Size of China public cloud market. Data source: CAICT; Sina.com.cn</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云市场规模。数据来源：中国信通技术；新浪网</span></p></blockquote></p><p> BABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.</p><p><blockquote>阿里巴巴在中国公有云市场拥有40%的份额，远远领先于其主要竞争对手。然而，值得注意的是，尽管处于领先地位，阿里巴巴仍处于大力投资模式，以继续扩大其市场份额，因为中国公共云市场预计将从2017年的264.8亿元增长到2023年的2307.4亿元，这将代表CAGR 43.4%，这是一个令人难以置信的出色增长率。当我们将中国的增长率与全球增长率（见下文）进行比较时，这一点尤其明显，因为全球公共云支出预计将从2017年的1450亿美元增长到2022年的3970亿美元，这将代表22.3%的CAGR。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/06198c569504bc303c34563041dfb294\" tg-width=\"600\" tg-height=\"371\"><span>Worldwide public cloud spending. Data source: Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云支出。数据来源：Gartner</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8482037f60575f964053ab732496bee3\" tg-width=\"1176\" tg-height=\"700\"><span>Worldwide public cloud market share. Source:CnTechPost; Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云市场份额。来源：CnTechPost；Gartner</span></p></blockquote></p><p> Therefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.</p><p><blockquote>因此，阿里云在2020年以9.5%的市场份额继续扩大对Alphabet（纳斯达克：GOOGL）（纳斯达克：GOOG）GCP的领先优势，我并不觉得奇怪。虽然亚马逊仍然是市场上明显的领导者，但随着公共云支出的持续扩大，其市场份额一直在大幅下降，这表明多个参与者存在巨大的增长潜力。凭借阿里巴巴在快速扩张的中国市场的领导地位，我越来越看好该细分市场未来的利润和自由现金流对阿里巴巴业绩的贡献。尽管阿里巴巴的云部门尚未实现息税前利润（21财年息税前利润率：-15%，20财年息税前利润率：-17.5%），但值得注意的是，Alphabet的GCP也尚未实现盈利（20财年息税前利润率：-42.9%，19财年息税前利润率：-52%）。因此，我们需要给阿里巴巴一些时间来扩大其在亚太地区和中国的云服务规模，预计阿里巴巴将拥有更强大的领导力，使其能够更快地增长，投资者应该预计随着时间的推移，这将是一个高利润的细分市场。</blockquote></p><p> <b>BABA's Valuations Look Highly Compelling</b></p><p><blockquote><b>阿里巴巴的估值看起来非常引人注目</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62a087c4b3ef7efc2c5dde813e3b959d\" tg-width=\"1000\" tg-height=\"600\"><span>NTM TEV / EBIT 3Y range.</span></p><p><blockquote><p class=\"t-img-caption\"><span>NTM TEV/EBIT 3Y范围。</span></p></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2605c0e5ad364a7a43929fef204595c\" tg-width=\"1280\" tg-height=\"687\"><span>EV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>EV/Fwd息税前利润和EV/Fwd Rev趋势。数据来源：标普资本智商</span></p></blockquote></p><p> When we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.</p><p><blockquote>当我们考虑阿里巴巴的TEV/EBIT历史范围（3年平均值为33.54倍）时，阿里巴巴的EV/Fwd EBIT趋势无疑意味着该股票被严重低估，因为预计阿里巴巴的收入和营业利润仍将快速增长。然而，由于我们希望更清楚地了解其同行的估值情况，我们认为如果我们对阿里巴巴的息税前利润进行估值，而不是下面介绍的一组基准公司，这将是有用的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d27873e676dfb23c98d4a69aa5861e02\" tg-width=\"1280\" tg-height=\"1117\"><span>Peers EV / EBIT Valuations. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行EV/EBIT估值。数据来源：标普资本智商</span></p></blockquote></p><p> By using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.</p><p><blockquote>通过混合使用历史和远期息税前利润，我们可以看到，与基准公司一组观察值的中值相比，阿里巴巴的EV/EBIT看起来确实被低估了。我们得出阿里巴巴的公允价值范围为294.98美元，位于该范围的中点，基于当前210美元的股价，这意味着40.5%的潜在上涨空间。</blockquote></p><p> <b>Risks to Assumptions</b></p><p><blockquote><b>假设风险</b></blockquote></p><p> Now, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.</p><p><blockquote>现在，看着先生如何表现显然令人困惑。市场决定对阿里巴巴进行折扣，就好像该公司已经失去了所有关键的增长来源，而事实上，其商业部门、新的市场举措和不断增长的阿里云部门仍有很大的潜在上涨空间，其中。我们认为该股表现不佳的主要现实原因只是监管风险。我们认为投资者应该承认这种风险是非常真实的，有时大型中国公司会发现自己受到中国政府的额外审查（事实上这并不是什么新鲜事）。这里关键的是，中国政府似乎对其科技巨头的行为和行动拥有重大影响力，而这些影响力有时可能在很大程度上是不可预测的。市场当然讨厌不可预测性，因此他们可能会因此大幅折扣阿里巴巴。如果投资者无法应对潜在不可预测的监管行动及其后果的不确定性，那么阿里巴巴可能不适合您。然而，如果你认为这只是阿里巴巴漫长旅程中的一个短暂时刻，那么你肯定会发现阿里巴巴现在的估值极具吸引力，再加上长期思维。</blockquote></p><p> <b>Wrapping It All Up</b></p><p><blockquote><b>把这一切包起来</b></blockquote></p><p> Alibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.</p><p><blockquote>阿里巴巴-SW继续取得稳健的业绩，展示了公司强大的执行能力。由于该公司继续在一个拥有如此多增长动力的市场中运营，预计将推动公司未来的增长，投资者应该会发现当前的估值非常有吸引力。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now\">seekingalpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-W"},"source_url":"https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175693382","content_text":"Summary\n\nAlibaba is probably the most undervalued growth stock right now.\nThe company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.\nThe short term technical picture may be turning bullish with a potential double bottom price action signal.\nWe discuss the company’s multiple growth drivers and let investors judge for themselves.\n\nYongyuan Dai/iStock Unreleased via Getty Images\nThe Technical Thesis\nSource: TradingView\nAlibaba’s stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.\nBABA's Fundamental Thesis: Rapidly Expanding Growth Drivers\nAnnual GMV. Data source: Company filings\nAnnual e-commerce revenue. Data source: Company filings\nBABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.\nEven though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.\nE-commerce revenue in the U.S. Data source: Statista\nWhen we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.\nPeers EBIT Margin and Projected EBIT Margin. Data source: S&P Capital IQ\nEven though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&A, and therefore skewed its EBIT margin to the downside.\nOne important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of 823M AAC in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only 100M AAC in Q2’C17 as compared to BABA’s 466M AAC in the same period.\nTherefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.\nMarket size of community group buying in China. Data source: iiMedia Research\nEven though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.\nPDD profitability metrics & revenue growth forecast. Data source: S&P Capital IQ\nWe could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.\nChina public cloud spending. Source:China Internet Watch; Canalys\nSize of China public cloud market. Data source: CAICT; Sina.com.cn\nBABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.\nWorldwide public cloud spending. Data source: Gartner\nWorldwide public cloud market share. Source:CnTechPost; Gartner\nTherefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.\nBABA's Valuations Look Highly Compelling\nNTM TEV / EBIT 3Y range.\nEV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&P Capital IQ\nWhen we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.\nPeers EV / EBIT Valuations. Data source: S&P Capital IQ\nBy using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.\nRisks to Assumptions\nNow, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.\nWrapping It All Up\nAlibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.","news_type":1,"symbols_score_info":{"BABA":0.9,"09988":0.9}},"isVote":1,"tweetType":1,"viewCount":2645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186321442,"gmtCreate":1623474566286,"gmtModify":1634032628625,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Please read...","listText":"Please read...","text":"Please read...","images":[{"img":"https://static.tigerbbs.com/4dd77cad77179db6ab7d9ee8b2068ea0","width":"1080","height":"1088"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186321442","isVote":1,"tweetType":1,"viewCount":1403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":340423530,"gmtCreate":1617457053320,"gmtModify":1634520886200,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Nicee","listText":"Nicee","text":"Nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/340423530","repostId":"2124875875","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340849768,"gmtCreate":1617377440354,"gmtModify":1631885696928,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ABNB\">$Airbnb, Inc.(ABNB)$</a>oh no","listText":"<a href=\"https://laohu8.com/S/ABNB\">$Airbnb, Inc.(ABNB)$</a>oh no","text":"$Airbnb, Inc.(ABNB)$oh no","images":[{"img":"https://static.tigerbbs.com/752d6e2d7c572d64f1b330d4a8c5e1bc","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/340849768","isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":340849990,"gmtCreate":1617377376210,"gmtModify":1634521176581,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Goooooddd","listText":"Goooooddd","text":"Goooooddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/340849990","repostId":"2124875875","repostType":4,"isVote":1,"tweetType":1,"viewCount":304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":356649668,"gmtCreate":1616774185854,"gmtModify":1634524042315,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Gooood","listText":"Gooood","text":"Gooood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/356649668","repostId":"1114428323","repostType":4,"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351250651,"gmtCreate":1616598849173,"gmtModify":1634524977969,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Coool","listText":"Coool","text":"Coool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/351250651","repostId":"1174857234","repostType":4,"repost":{"id":"1174857234","kind":"news","pubTimestamp":1616597621,"share":"https://www.laohu8.com/m/news/1174857234?lang=zh_CN&edition=full","pubTime":"2021-03-24 22:53","market":"us","language":"en","title":"These Stocks Are Set to Benefit from Intel’s $20 Billion Manufacturing Plan<blockquote>这些股票将受益于英特尔200亿美元的制造计划</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1174857234","media":"Barrons","summary":"Intel’s $20 billion plan to ramp up semiconductor manufacturing may be just the crest of a wave of c","content":"<p>Intel’s $20 billion plan to ramp up semiconductor manufacturing may be just the crest of a wave of capital spending across chip makers in the next few years, making companies on the equipment side of the industry well-positioned to benefit, according to investment bank Berenberg.</p><p><blockquote>投资银行Berenberg表示，英特尔200亿美元的半导体制造计划可能只是未来几年芯片制造商资本支出浪潮的顶峰，这使得该行业设备方面的公司处于有利地位，可以从中受益。</blockquote></p><p>Shares in European companies that design and build equipment used in making semiconductors jumped up on Wednesday, as the market had its first chance to react to Intel’s plan.ASML&nbsp;stock surged 5%, while shares in&nbsp;ASM International&nbsp;jumped 8% and&nbsp;Besi&nbsp;stock lifted 4%.</p><p><blockquote>设计和制造半导体制造设备的欧洲公司股价周三上涨，市场首次有机会对英特尔的计划做出反应。ASML股价飙升5%，ASM International股价上涨8%，Besi股价上涨4%。</blockquote></p><p><b>The back story.</b>U.S. chip giant&nbsp;Intel&nbsp;said late on Tuesday that it would spend $20 billion to build two new plants in Arizona. The decision to expand the company’s manufacturing capability over the long term comes just weeks into Pat Gelsinger’s tenure as chief executive. The plan will ramp up capital spending for the chip maker this year from the around $14.7 billion expected by analysts to between $19 billion and $20 billion.</p><p><blockquote><b>背景故事。</b>美国芯片巨头英特尔周二晚些时候表示，将斥资200亿美元在亚利桑那州新建两家工厂。帕特·基辛格(Pat Gelsinger)就任首席执行官仅几周后，就做出了长期扩大公司制造能力的决定。该计划将把这家芯片制造商今年的资本支出从分析师预期的147亿美元左右提高到190亿至200亿美元之间。</blockquote></p><p>Intel’s decision comes amid a global semiconductor shortage that has impacted industries from personal electronics to automobiles. The U.S. government has increasingly signaled that it wants to secure domestic chip supplies, as much of the semiconductor industry is centered on East Asia. Gelsinger said that the chip shortage could last for at least two years—around the time that it takes to build new plants.</p><p><blockquote>英特尔做出这一决定之际，全球半导体短缺已经影响了从个人电子产品到汽车等行业。由于半导体行业的大部分集中在东亚，美国政府越来越多地表示希望确保国内芯片供应。基辛格表示，芯片短缺可能会持续至少两年——大约是建造新工厂所需的时间。</blockquote></p><p><b>What’s new.</b>Analyst Tammy Qiu of Berenberg said on Wednesday that the investment bank had raised its expectations for global capital expenditures in the semiconductor industry in 2021. The bank now estimates capital expenditure for the sector to rise 18% from 2020 levels, up from the midteens figure previously expected. Berenberg also expects Intel’s capital spending to remain high in the near future, in line with the company’s ambitious technology road map.</p><p><blockquote><b>什么是新的。</b>Berenberg分析师Tammy Qiu周三表示，该投行上调了对2021年全球半导体行业资本支出的预期。该银行目前预计该行业的资本支出将比2020年的水平增长18%，高于此前预期的十几岁左右的数字。Berenberg还预计，英特尔的资本支出在不久的将来仍将保持高位，这符合该公司雄心勃勃的技术路线图。</blockquote></p><p>One company in particular is expected to benefit from Intel’s plans, according to Berenberg. Dutch company ASML, which supplies Intel, TSMC, and&nbsp;Samsung Electronics,holds a near-monopoly on the lithography systems critical to the chip-making process. The group, which is dual-listed on Amsterdam’s&nbsp;Euronextand on the Nasdaq, is also a pioneer in extreme-ultraviolet (EUV) lithography. In Berenberg’s view, Intel’s business update suggests the group is “fully committed” to EUV, which is the much-anticipated next generation of the technology.</p><p><blockquote>贝伦贝格表示，预计有一家公司将从英特尔的计划中受益。为英特尔、台积电和三星电子供货的荷兰公司ASML几乎垄断了对芯片制造过程至关重要的光刻系统。该集团在纳斯达克泛欧交易所双重上市，也是极紫外(EUV)光刻领域的先驱。在Berenberg看来，英特尔的业务更新表明该集团“完全致力于”EUV，这是备受期待的下一代技术。</blockquote></p><p>“As a result, we expect Intel to be more active in ordering and adopting EUV in its manufacturing process in the future,” Qiu said. “In response, we expect TSMC to continue to stay aggressive with its road map. All this will lead to more demand for EUV tools.”</p><p><blockquote>“因此，我们预计英特尔未来将更加积极地订购和在其制造过程中采用EUV，”邱说。“作为回应，我们预计台积电将继续积极推行其路线图。所有这些都将导致对EUV工具的更多需求。”</blockquote></p><p>As Intel and TSMC continue to compete and spend aggressively on leading-edge technology, Berenberg predicts the positive effects will be felt by the equipment side of the industry for years to come. Equipment groups outside of the European stocks that jumped on Wednesday are poised to benefit, according to the investment bank, including U.S.-based&nbsp;Applied Materials,Lam Research,and KLA Corporation.</p><p><blockquote>随着英特尔和台积电继续竞争并在领先技术上大举投资，贝伦贝格预测，未来几年，该行业的设备方面将感受到积极的影响。该投资银行表示，周三上涨的欧洲股市以外的设备集团也将受益，其中包括美国应用材料公司、泛林研究公司和KLA公司。</blockquote></p><p><b>Looking ahead.</b>Gelsinger in part blamed the Covid-19 pandemic for the global chip shortage, because of the rapid shift to digital platforms—by working from home—that has occurred over the past year. Even as the pandemic fades, it is expected that many consumer and industry trends will stick around, and Intel’s prediction that the shortage will last at least two years means investors will be talking about chip stocks for a long time.</p><p><blockquote><b>展望未来。</b>基辛格将全球芯片短缺部分归咎于Covid-19大流行，因为过去一年发生了向数字平台（在家工作）的快速转变。即使疫情消退，预计许多消费者和行业趋势仍将持续，英特尔预测短缺将持续至少两年，这意味着投资者将在很长一段时间内谈论芯片股。</blockquote></p><p>Berenberg’s price target for ASML is €540, with the stock trading at €496 on Wednesday. The investment bank’s price targets on other equipment manufacturers suggest stocks across the sector have legs to run higher.</p><p><blockquote>Berenberg对ASML的目标价为540欧元，周三该股交易价格为496欧元。该投资银行对其他设备制造商的目标价表明，整个行业的股票都有走高的空间。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Stocks Are Set to Benefit from Intel’s $20 Billion Manufacturing Plan<blockquote>这些股票将受益于英特尔200亿美元的制造计划</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Stocks Are Set to Benefit from Intel’s $20 Billion Manufacturing Plan<blockquote>这些股票将受益于英特尔200亿美元的制造计划</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-03-24 22:53</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Intel’s $20 billion plan to ramp up semiconductor manufacturing may be just the crest of a wave of capital spending across chip makers in the next few years, making companies on the equipment side of the industry well-positioned to benefit, according to investment bank Berenberg.</p><p><blockquote>投资银行Berenberg表示，英特尔200亿美元的半导体制造计划可能只是未来几年芯片制造商资本支出浪潮的顶峰，这使得该行业设备方面的公司处于有利地位，可以从中受益。</blockquote></p><p>Shares in European companies that design and build equipment used in making semiconductors jumped up on Wednesday, as the market had its first chance to react to Intel’s plan.ASML&nbsp;stock surged 5%, while shares in&nbsp;ASM International&nbsp;jumped 8% and&nbsp;Besi&nbsp;stock lifted 4%.</p><p><blockquote>设计和制造半导体制造设备的欧洲公司股价周三上涨，市场首次有机会对英特尔的计划做出反应。ASML股价飙升5%，ASM International股价上涨8%，Besi股价上涨4%。</blockquote></p><p><b>The back story.</b>U.S. chip giant&nbsp;Intel&nbsp;said late on Tuesday that it would spend $20 billion to build two new plants in Arizona. The decision to expand the company’s manufacturing capability over the long term comes just weeks into Pat Gelsinger’s tenure as chief executive. The plan will ramp up capital spending for the chip maker this year from the around $14.7 billion expected by analysts to between $19 billion and $20 billion.</p><p><blockquote><b>背景故事。</b>美国芯片巨头英特尔周二晚些时候表示，将斥资200亿美元在亚利桑那州新建两家工厂。帕特·基辛格(Pat Gelsinger)就任首席执行官仅几周后，就做出了长期扩大公司制造能力的决定。该计划将把这家芯片制造商今年的资本支出从分析师预期的147亿美元左右提高到190亿至200亿美元之间。</blockquote></p><p>Intel’s decision comes amid a global semiconductor shortage that has impacted industries from personal electronics to automobiles. The U.S. government has increasingly signaled that it wants to secure domestic chip supplies, as much of the semiconductor industry is centered on East Asia. Gelsinger said that the chip shortage could last for at least two years—around the time that it takes to build new plants.</p><p><blockquote>英特尔做出这一决定之际，全球半导体短缺已经影响了从个人电子产品到汽车等行业。由于半导体行业的大部分集中在东亚，美国政府越来越多地表示希望确保国内芯片供应。基辛格表示，芯片短缺可能会持续至少两年——大约是建造新工厂所需的时间。</blockquote></p><p><b>What’s new.</b>Analyst Tammy Qiu of Berenberg said on Wednesday that the investment bank had raised its expectations for global capital expenditures in the semiconductor industry in 2021. The bank now estimates capital expenditure for the sector to rise 18% from 2020 levels, up from the midteens figure previously expected. Berenberg also expects Intel’s capital spending to remain high in the near future, in line with the company’s ambitious technology road map.</p><p><blockquote><b>什么是新的。</b>Berenberg分析师Tammy Qiu周三表示，该投行上调了对2021年全球半导体行业资本支出的预期。该银行目前预计该行业的资本支出将比2020年的水平增长18%，高于此前预期的十几岁左右的数字。Berenberg还预计，英特尔的资本支出在不久的将来仍将保持高位，这符合该公司雄心勃勃的技术路线图。</blockquote></p><p>One company in particular is expected to benefit from Intel’s plans, according to Berenberg. Dutch company ASML, which supplies Intel, TSMC, and&nbsp;Samsung Electronics,holds a near-monopoly on the lithography systems critical to the chip-making process. The group, which is dual-listed on Amsterdam’s&nbsp;Euronextand on the Nasdaq, is also a pioneer in extreme-ultraviolet (EUV) lithography. In Berenberg’s view, Intel’s business update suggests the group is “fully committed” to EUV, which is the much-anticipated next generation of the technology.</p><p><blockquote>贝伦贝格表示，预计有一家公司将从英特尔的计划中受益。为英特尔、台积电和三星电子供货的荷兰公司ASML几乎垄断了对芯片制造过程至关重要的光刻系统。该集团在纳斯达克泛欧交易所双重上市，也是极紫外(EUV)光刻领域的先驱。在Berenberg看来，英特尔的业务更新表明该集团“完全致力于”EUV，这是备受期待的下一代技术。</blockquote></p><p>“As a result, we expect Intel to be more active in ordering and adopting EUV in its manufacturing process in the future,” Qiu said. “In response, we expect TSMC to continue to stay aggressive with its road map. All this will lead to more demand for EUV tools.”</p><p><blockquote>“因此，我们预计英特尔未来将更加积极地订购和在其制造过程中采用EUV，”邱说。“作为回应，我们预计台积电将继续积极推行其路线图。所有这些都将导致对EUV工具的更多需求。”</blockquote></p><p>As Intel and TSMC continue to compete and spend aggressively on leading-edge technology, Berenberg predicts the positive effects will be felt by the equipment side of the industry for years to come. Equipment groups outside of the European stocks that jumped on Wednesday are poised to benefit, according to the investment bank, including U.S.-based&nbsp;Applied Materials,Lam Research,and KLA Corporation.</p><p><blockquote>随着英特尔和台积电继续竞争并在领先技术上大举投资，贝伦贝格预测，未来几年，该行业的设备方面将感受到积极的影响。该投资银行表示，周三上涨的欧洲股市以外的设备集团也将受益，其中包括美国应用材料公司、泛林研究公司和KLA公司。</blockquote></p><p><b>Looking ahead.</b>Gelsinger in part blamed the Covid-19 pandemic for the global chip shortage, because of the rapid shift to digital platforms—by working from home—that has occurred over the past year. Even as the pandemic fades, it is expected that many consumer and industry trends will stick around, and Intel’s prediction that the shortage will last at least two years means investors will be talking about chip stocks for a long time.</p><p><blockquote><b>展望未来。</b>基辛格将全球芯片短缺部分归咎于Covid-19大流行，因为过去一年发生了向数字平台（在家工作）的快速转变。即使疫情消退，预计许多消费者和行业趋势仍将持续，英特尔预测短缺将持续至少两年，这意味着投资者将在很长一段时间内谈论芯片股。</blockquote></p><p>Berenberg’s price target for ASML is €540, with the stock trading at €496 on Wednesday. The investment bank’s price targets on other equipment manufacturers suggest stocks across the sector have legs to run higher.</p><p><blockquote>Berenberg对ASML的目标价为540欧元，周三该股交易价格为496欧元。该投资银行对其他设备制造商的目标价表明，整个行业的股票都有走高的空间。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/these-stocks-are-set-to-benefit-from-intels-20-billion-manufacturing-plan-51616594149?mod=RTA\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KLAQ":"KL Acquisition Corp","LRCX":"拉姆研究","ASML":"阿斯麦","BESIY":"BE Semiconductor Industries N.V.","AMAT":"应用材料","ASMIY":"ASM International N.V.","INTC":"英特尔"},"source_url":"https://www.barrons.com/articles/these-stocks-are-set-to-benefit-from-intels-20-billion-manufacturing-plan-51616594149?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174857234","content_text":"Intel’s $20 billion plan to ramp up semiconductor manufacturing may be just the crest of a wave of capital spending across chip makers in the next few years, making companies on the equipment side of the industry well-positioned to benefit, according to investment bank Berenberg.Shares in European companies that design and build equipment used in making semiconductors jumped up on Wednesday, as the market had its first chance to react to Intel’s plan.ASML stock surged 5%, while shares in ASM International jumped 8% and Besi stock lifted 4%.The back story.U.S. chip giant Intel said late on Tuesday that it would spend $20 billion to build two new plants in Arizona. The decision to expand the company’s manufacturing capability over the long term comes just weeks into Pat Gelsinger’s tenure as chief executive. The plan will ramp up capital spending for the chip maker this year from the around $14.7 billion expected by analysts to between $19 billion and $20 billion.Intel’s decision comes amid a global semiconductor shortage that has impacted industries from personal electronics to automobiles. The U.S. government has increasingly signaled that it wants to secure domestic chip supplies, as much of the semiconductor industry is centered on East Asia. Gelsinger said that the chip shortage could last for at least two years—around the time that it takes to build new plants.What’s new.Analyst Tammy Qiu of Berenberg said on Wednesday that the investment bank had raised its expectations for global capital expenditures in the semiconductor industry in 2021. The bank now estimates capital expenditure for the sector to rise 18% from 2020 levels, up from the midteens figure previously expected. Berenberg also expects Intel’s capital spending to remain high in the near future, in line with the company’s ambitious technology road map.One company in particular is expected to benefit from Intel’s plans, according to Berenberg. Dutch company ASML, which supplies Intel, TSMC, and Samsung Electronics,holds a near-monopoly on the lithography systems critical to the chip-making process. The group, which is dual-listed on Amsterdam’s Euronextand on the Nasdaq, is also a pioneer in extreme-ultraviolet (EUV) lithography. In Berenberg’s view, Intel’s business update suggests the group is “fully committed” to EUV, which is the much-anticipated next generation of the technology.“As a result, we expect Intel to be more active in ordering and adopting EUV in its manufacturing process in the future,” Qiu said. “In response, we expect TSMC to continue to stay aggressive with its road map. All this will lead to more demand for EUV tools.”As Intel and TSMC continue to compete and spend aggressively on leading-edge technology, Berenberg predicts the positive effects will be felt by the equipment side of the industry for years to come. Equipment groups outside of the European stocks that jumped on Wednesday are poised to benefit, according to the investment bank, including U.S.-based Applied Materials,Lam Research,and KLA Corporation.Looking ahead.Gelsinger in part blamed the Covid-19 pandemic for the global chip shortage, because of the rapid shift to digital platforms—by working from home—that has occurred over the past year. Even as the pandemic fades, it is expected that many consumer and industry trends will stick around, and Intel’s prediction that the shortage will last at least two years means investors will be talking about chip stocks for a long time.Berenberg’s price target for ASML is €540, with the stock trading at €496 on Wednesday. The investment bank’s price targets on other equipment manufacturers suggest stocks across the sector have legs to run higher.","news_type":1,"symbols_score_info":{"BESIY":0.9,"INTC":0.9,"KLAQ":0.9,"LRCX":0.9,"ASMIY":0.9,"ASML":0.9,"AMAT":0.9}},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":353893526,"gmtCreate":1616476795765,"gmtModify":1634525613720,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Buyyy","listText":"Buyyy","text":"Buyyy","images":[{"img":"https://static.tigerbbs.com/c3a2649da8916610194f86f4ffb677b4","width":"1080","height":"2709"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/353893526","isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":353893991,"gmtCreate":1616476745813,"gmtModify":1634525614203,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"I see. Cool","listText":"I see. Cool","text":"I see. Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/353893991","repostId":"1113268864","repostType":4,"isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":353899527,"gmtCreate":1616476716869,"gmtModify":1634525614443,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/353899527","repostId":"2121101257","repostType":4,"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359842056,"gmtCreate":1616386744475,"gmtModify":1634526121596,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Goodfdf","listText":"Goodfdf","text":"Goodfdf","images":[{"img":"https://static.tigerbbs.com/93fefb9197fa53b3722fc7ebe3dc16c9","width":"1080","height":"2709"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/359842056","isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":359846755,"gmtCreate":1616386703577,"gmtModify":1634526121718,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/359846755","repostId":"2121140614","repostType":4,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":359846393,"gmtCreate":1616386652212,"gmtModify":1634526122200,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/359846393","repostId":"1142823107","repostType":4,"repost":{"id":"1142823107","kind":"news","pubTimestamp":1616384869,"share":"https://www.laohu8.com/m/news/1142823107?lang=zh_CN&edition=full","pubTime":"2021-03-22 11:47","market":"us","language":"en","title":"Australia's Crown Resorts receives $6.2 billion proposal from Blackstone<blockquote>澳大利亚皇冠度假村收到黑石集团62亿美元的报价</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142823107","media":"reuters","summary":"(Reuters) - Troubled Australian casino operator Crown Resorts Ltd on Monday said it had received a c","content":"<p>(Reuters) - Troubled Australian casino operator Crown Resorts Ltd on Monday said it had received a conditional buyout proposal from U.S. private equity giant Blackstone, sending its shares 19% higher.</p><p><blockquote>（路透社）-陷入困境的澳大利亚赌场运营商皇冠度假村有限公司周一表示，已收到美国私募股权巨头黑石集团的有条件收购提议，其股价上涨19%。</blockquote></p><p> The indicative proposal comes as casinos and gaming operators around the world have seen values plunge as coronavirus lockdowns battered earnings, putting them on the radar of cashed-up investment firms.</p><p><blockquote>这项指示性提议出台之际，世界各地的赌场和博彩运营商因冠状病毒封锁打击盈利而股价暴跌，使它们受到现金充裕的投资公司的关注。</blockquote></p><p> Crown has suffered more than most after a year-long regulatory inquiry aired allegations of money laundering and governance failures at the company, leading to the loss of its gambling licence for its new A$2.2 billion Sydney casino last month.</p><p><blockquote>在长达一年的监管调查公布了该公司洗钱和治理失败的指控后，皇冠遭受的损失超过了大多数公司，导致其价值22亿澳元的新悉尼赌场上个月失去了赌博许可证。</blockquote></p><p> Since then, top executives including its chief executive resigned, paving the way for Crown to repair its reputation and regain its licence with ex-federal communications minister and Chairman Helen Coonan at the helm of the overhaul.</p><p><blockquote>此后，包括首席执行官在内的高管辞职，为皇冠修复声誉并在前联邦通信部长兼董事长海伦·库南(Helen Coonan)领导下重新获得执照铺平了道路。</blockquote></p><p> Crown said Blackstone’s proposal was A$11.85 per share, a premium of 20.2% to the company’s last closing price, and valuing it at A$8.02 billion ($6.2 billion).</p><p><blockquote>Crown表示，黑石的报价为每股11.85澳元，较公司最后收盘价溢价20.2%，估值为80.2亿澳元（合62亿美元）。</blockquote></p><p> Its shares jumped to A$11.750 following news of the proposal on Monday, their highest in a year. The stock fell nearly 20% in 2020 as the inquiry exposed major flaws in the company’s governance.</p><p><blockquote>周一该提议的消息传出后，其股价跃升至11.750澳元，为一年来的最高水平。由于调查暴露了公司治理的重大缺陷，该股在2020年下跌了近20%。</blockquote></p><p> Blackstone currently has a 10% stake in Crown which it bought from Macau’s Melco Resorts &amp; Entertainment in April last year at just A$8.15 per share, and is the second-largest holder after billionaire founder James Packer.</p><p><blockquote>黑石目前拥有皇冠10%的股份，该公司于去年4月以每股8.15澳元的价格从澳门新濠博亚娱乐公司收购了皇冠10%的股份，是仅次于亿万富翁创始人詹姆斯·帕克的第二大股东。</blockquote></p><p> The company’s board had not yet formed a view on the offer, which was subject to conditions including due diligence, arranging debt finance and Blackstone receiving gambling approvals to allow it to operate Crown’s Sydney, Melbourne and Perth licences, the company said in a statement.</p><p><blockquote>该公司在一份声明中表示，该公司董事会尚未对该要约形成看法，该要约须满足尽职调查、安排债务融资以及黑石获得赌博批准以允许其经营皇冠悉尼、墨尔本和珀斯牌照等条件。</blockquote></p><p> Blackstone most recently acquired the Bellagio in Las Vegas for $4.25 billion, and also owns a casino resort called “The Cosmopolitan” in Las Vegas and Spanish gaming hall operator Cirsa.</p><p><blockquote>黑石最近以42.5亿美元收购了拉斯维加斯的Bellagio，还在拉斯维加斯拥有一家名为“The Cosmopolitan”的赌场度假村和西班牙游戏厅运营商Cirsa。</blockquote></p><p> ($1 = 1.2967 Australian dollars)</p><p><blockquote>（1美元=1.2967澳元）</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Australia's Crown Resorts receives $6.2 billion proposal from Blackstone<blockquote>澳大利亚皇冠度假村收到黑石集团62亿美元的报价</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAustralia's Crown Resorts receives $6.2 billion proposal from Blackstone<blockquote>澳大利亚皇冠度假村收到黑石集团62亿美元的报价</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">reuters</strong><span class=\"h-time small\">2021-03-22 11:47</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - Troubled Australian casino operator Crown Resorts Ltd on Monday said it had received a conditional buyout proposal from U.S. private equity giant Blackstone, sending its shares 19% higher.</p><p><blockquote>（路透社）-陷入困境的澳大利亚赌场运营商皇冠度假村有限公司周一表示，已收到美国私募股权巨头黑石集团的有条件收购提议，其股价上涨19%。</blockquote></p><p> The indicative proposal comes as casinos and gaming operators around the world have seen values plunge as coronavirus lockdowns battered earnings, putting them on the radar of cashed-up investment firms.</p><p><blockquote>这项指示性提议出台之际，世界各地的赌场和博彩运营商因冠状病毒封锁打击盈利而股价暴跌，使它们受到现金充裕的投资公司的关注。</blockquote></p><p> Crown has suffered more than most after a year-long regulatory inquiry aired allegations of money laundering and governance failures at the company, leading to the loss of its gambling licence for its new A$2.2 billion Sydney casino last month.</p><p><blockquote>在长达一年的监管调查公布了该公司洗钱和治理失败的指控后，皇冠遭受的损失超过了大多数公司，导致其价值22亿澳元的新悉尼赌场上个月失去了赌博许可证。</blockquote></p><p> Since then, top executives including its chief executive resigned, paving the way for Crown to repair its reputation and regain its licence with ex-federal communications minister and Chairman Helen Coonan at the helm of the overhaul.</p><p><blockquote>此后，包括首席执行官在内的高管辞职，为皇冠修复声誉并在前联邦通信部长兼董事长海伦·库南(Helen Coonan)领导下重新获得执照铺平了道路。</blockquote></p><p> Crown said Blackstone’s proposal was A$11.85 per share, a premium of 20.2% to the company’s last closing price, and valuing it at A$8.02 billion ($6.2 billion).</p><p><blockquote>Crown表示，黑石的报价为每股11.85澳元，较公司最后收盘价溢价20.2%，估值为80.2亿澳元（合62亿美元）。</blockquote></p><p> Its shares jumped to A$11.750 following news of the proposal on Monday, their highest in a year. The stock fell nearly 20% in 2020 as the inquiry exposed major flaws in the company’s governance.</p><p><blockquote>周一该提议的消息传出后，其股价跃升至11.750澳元，为一年来的最高水平。由于调查暴露了公司治理的重大缺陷，该股在2020年下跌了近20%。</blockquote></p><p> Blackstone currently has a 10% stake in Crown which it bought from Macau’s Melco Resorts &amp; Entertainment in April last year at just A$8.15 per share, and is the second-largest holder after billionaire founder James Packer.</p><p><blockquote>黑石目前拥有皇冠10%的股份，该公司于去年4月以每股8.15澳元的价格从澳门新濠博亚娱乐公司收购了皇冠10%的股份，是仅次于亿万富翁创始人詹姆斯·帕克的第二大股东。</blockquote></p><p> The company’s board had not yet formed a view on the offer, which was subject to conditions including due diligence, arranging debt finance and Blackstone receiving gambling approvals to allow it to operate Crown’s Sydney, Melbourne and Perth licences, the company said in a statement.</p><p><blockquote>该公司在一份声明中表示，该公司董事会尚未对该要约形成看法，该要约须满足尽职调查、安排债务融资以及黑石获得赌博批准以允许其经营皇冠悉尼、墨尔本和珀斯牌照等条件。</blockquote></p><p> Blackstone most recently acquired the Bellagio in Las Vegas for $4.25 billion, and also owns a casino resort called “The Cosmopolitan” in Las Vegas and Spanish gaming hall operator Cirsa.</p><p><blockquote>黑石最近以42.5亿美元收购了拉斯维加斯的Bellagio，还在拉斯维加斯拥有一家名为“The Cosmopolitan”的赌场度假村和西班牙游戏厅运营商Cirsa。</blockquote></p><p> ($1 = 1.2967 Australian dollars)</p><p><blockquote>（1美元=1.2967澳元）</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/us-crown-resorts-m-a-blackstone-group/blackstone-proposal-values-australian-casino-operator-crown-at-6-2-billion-idUSKBN2BD0SM?il=0\">reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BX":"黑石"},"source_url":"https://www.reuters.com/article/us-crown-resorts-m-a-blackstone-group/blackstone-proposal-values-australian-casino-operator-crown-at-6-2-billion-idUSKBN2BD0SM?il=0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142823107","content_text":"(Reuters) - Troubled Australian casino operator Crown Resorts Ltd on Monday said it had received a conditional buyout proposal from U.S. private equity giant Blackstone, sending its shares 19% higher.\nThe indicative proposal comes as casinos and gaming operators around the world have seen values plunge as coronavirus lockdowns battered earnings, putting them on the radar of cashed-up investment firms.\nCrown has suffered more than most after a year-long regulatory inquiry aired allegations of money laundering and governance failures at the company, leading to the loss of its gambling licence for its new A$2.2 billion Sydney casino last month.\nSince then, top executives including its chief executive resigned, paving the way for Crown to repair its reputation and regain its licence with ex-federal communications minister and Chairman Helen Coonan at the helm of the overhaul.\nCrown said Blackstone’s proposal was A$11.85 per share, a premium of 20.2% to the company’s last closing price, and valuing it at A$8.02 billion ($6.2 billion).\nIts shares jumped to A$11.750 following news of the proposal on Monday, their highest in a year. The stock fell nearly 20% in 2020 as the inquiry exposed major flaws in the company’s governance.\nBlackstone currently has a 10% stake in Crown which it bought from Macau’s Melco Resorts & Entertainment in April last year at just A$8.15 per share, and is the second-largest holder after billionaire founder James Packer.\nThe company’s board had not yet formed a view on the offer, which was subject to conditions including due diligence, arranging debt finance and Blackstone receiving gambling approvals to allow it to operate Crown’s Sydney, Melbourne and Perth licences, the company said in a statement.\nBlackstone most recently acquired the Bellagio in Las Vegas for $4.25 billion, and also owns a casino resort called “The Cosmopolitan” in Las Vegas and Spanish gaming hall operator Cirsa.\n($1 = 1.2967 Australian dollars)","news_type":1,"symbols_score_info":{"BX":0.9}},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":698952783,"gmtCreate":1640286687678,"gmtModify":1640286687754,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698952783","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=zh_CN&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">SeattleTimes</strong><span class=\"h-time small\">2021-12-23 22:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">SeattleTimes</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":353899527,"gmtCreate":1616476716869,"gmtModify":1634525614443,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/353899527","repostId":"2121101257","repostType":4,"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":353893991,"gmtCreate":1616476745813,"gmtModify":1634525614203,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"I see. Cool","listText":"I see. Cool","text":"I see. Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/353893991","repostId":"1113268864","repostType":4,"isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":698952835,"gmtCreate":1640286465896,"gmtModify":1640286465896,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698952835","repostId":"1199712599","repostType":4,"repost":{"id":"1199712599","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640269826,"share":"https://www.laohu8.com/m/news/1199712599?lang=zh_CN&edition=full","pubTime":"2021-12-23 22:30","market":"us","language":"en","title":"Stocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199712599","media":"Tiger Newspress","summary":"All three major averages were up Thursday morning, building on back-to-back sessions of gains as fea","content":"<p>All three major averages were up Thursday morning, building on back-to-back sessions of gains as fears the Omicron variant would derail economic growth cooled among investors who sold-off risky assets at the start of the week on reports of swelling case numbers.</p><p><blockquote>周四上午，三大股指均在连续几个交易日上涨的基础上上涨，原因是投资者对奥密克戎变体将破坏经济增长的担忧降温，他们在本周初因病例数量激增而抛售风险资产。</blockquote></p><p> The Nasdaq briefly jumped 180 points, while the Dow Industrial Average and S&amp;P 500 also edged higher.</p><p><blockquote>纳斯达克短暂上涨180点，道琼斯工业平均指数和标普500也小幅走高。</blockquote></p><p> Investors are weighing a trove of economic releases this morning. The Labor Department reported that initial jobless claims&nbsp;totaled 205,000, sustaining a downward trend&nbsp;from the highs of their pandemic peak and reflecting labor market tightness brought on by a demand for workers heading into the new year. The latest print brings the four-week moving average for new claims to its lowest in 52 years, ticking up by 2,750 week-over-week to reach 206,250.</p><p><blockquote>投资者今天上午正在权衡一系列经济数据。美国劳工部报告称，首次申请失业救济人数总计20.5万人，较疫情峰值保持下降趋势，反映出进入新的一年对工人的需求带来的劳动力市场紧张。最新数据显示，新申请失业救济人数的四周移动平均值降至52年来的最低水平，周环比增加2,750人，达到206,250人。</blockquote></p><p> U.S. durable goods orders rose by 2.5% in November, up from the prior month, boosted by a sharp rise in aircraft orders.</p><p><blockquote>受飞机订单大幅上升提振，美国11月耐用品订单环比增长2.5%。</blockquote></p><p> Meanwhile, U.S. consumer prices&nbsp;accelerated at the fastest pace&nbsp;in nearly four decades as shoppers confront rising inflation levels ahead of the holidays.</p><p><blockquote>与此同时，由于购物者在假期前面临通胀水平上升，美国消费者价格以近四十年来最快的速度上涨。</blockquote></p><p> In Wednesday's trading session, investors weighed an upbeat print on consumer confidence levels and the release of an upwardly revised estimate for domestic GDP, placing all three major averages in the green after a mixed open.</p><p><blockquote>在周三的交易时段，投资者权衡了消费者信心水平的乐观情绪和国内GDP预估上调的发布，三大股指在开盘涨跌互现后均呈绿色。</blockquote></p><p> The Conference Board reported consumer confidence&nbsp;increased by a greater-than-expected margin in December,with the headline index at 115.8 during the month and higher than Bloomberg’s consensus estimates of 111.0. In November, the index had a reading of 111.9, revised from an initial report of 109.5. Meanwhile, the nation’s gross domestic product grew at an annual rate of 2.3% in the third quarter in the final estimate from the Bureau of Economic Analysis after the initial report of 2.1%.</p><p><blockquote>世界大型企业联合会报告称，12月份消费者信心增幅超出预期，当月总体指数为115.8，高于彭博社普遍预期的111.0。11月份，该指数读数为111.9，高于最初报告的109.5。与此同时，经济分析局在最初报告为2.1%后，最终估计第三季度美国国内生产总值年增长率为2.3%。</blockquote></p><p> “We’ve been saying that this is definitely a buy the dip sort of market because we expect more earnings upgrades to come,” Anik Sen, PineBridge Investments global head of equities&nbsp;told Yahoo Finance Live. “We think that the real debate should be about the length and strength of the economic cycle ahead.”</p><p><blockquote>PineBridge Investments全球股票主管阿尼克·森(Anik Sen)对雅虎财经直播表示：“我们一直在说，这绝对是一个逢低买入的市场，因为我们预计将出现更多盈利上调。”“我们认为真正的争论应该是关于未来经济周期的长度和强度。”</blockquote></p><p> The clock is also ticking on ayear-end Santa Claus Rally— one in which stocks climb higher in the final seven trading sessions of a year, plus the first two trading days of the new year. Starting tomorrow, traders will see whether 92 years of data uphold.</p><p><blockquote>年终圣诞老人反弹的时间也在流逝——股市在一年的最后七个交易日以及新年的前两个交易日攀升。从明天开始，交易者将看到92年的数据是否成立。</blockquote></p><p> For reasons unclear, over the past 92 years, the S&amp;P 500 gained 77% of the time during the year-end rally period, according to data from Sundial Capital Research. The average gain in this nine-day trading period tallied 2.66%.</p><p><blockquote>Sundial Capital Research的数据显示，出于尚不清楚的原因，在过去92年中，标普500在年终反弹期间有77%的时间上涨。这九天交易期间的平均涨幅为2.66%。</blockquote></p><p> Separately, Oppenheimer chief investment strategistJohn Stoltzfusdisclosedthe most bullish price target on the S&amp;P 500, forecasting a 14% climb to 5,330 by the end of 2022. The 38-year Wall Street veteran’s estimate beats even the most optimistic of his peers, BMO Capital Markets’s Brian Belski, who projected S&amp;P 500 5,300.</p><p><blockquote>另外，Oppenheimer首席投资策略师John Stoltzfus披露了标普500最乐观的目标价，预测到2022年底将上涨14%至5,330点。这位38岁的华尔街资深人士的预测甚至超过了最乐观的同行BMO Capital Markets的Brian Belski，后者预测标普500为5,300点。</blockquote></p><p> Meanwile, Pfizer (PFE)received authorization from the U.S. Food and Drug Administration for its at-home COVID-19 pill&nbsp;following clinical trial data that showed the treatment was 90% effective at preventing hospitalizations and deaths in high-risk patients. Shares of Pfizer gained more than 2% in Wednesday's session following the news and closed up 1.02% at $59.55 a piece.</p><p><blockquote>与此同时，辉瑞（PFE）获得了美国的授权。美国食品药品监督管理局对其家用COVID-19药丸进行了临床试验数据显示，该治疗在预防高危患者住院和死亡方面有90%的有效性。消息传出后，辉瑞股价在周三交易中上涨超过2%，收盘上涨1.02%，至每股59.55美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise for a third day from omicron scare, Dow rises 100 points<blockquote>奥密克戎恐慌导致股市连续第三天上涨，道琼斯指数上涨100点</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-23 22:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>All three major averages were up Thursday morning, building on back-to-back sessions of gains as fears the Omicron variant would derail economic growth cooled among investors who sold-off risky assets at the start of the week on reports of swelling case numbers.</p><p><blockquote>周四上午，三大股指均在连续几个交易日上涨的基础上上涨，原因是投资者对奥密克戎变体将破坏经济增长的担忧降温，他们在本周初因病例数量激增而抛售风险资产。</blockquote></p><p> The Nasdaq briefly jumped 180 points, while the Dow Industrial Average and S&amp;P 500 also edged higher.</p><p><blockquote>纳斯达克短暂上涨180点，道琼斯工业平均指数和标普500也小幅走高。</blockquote></p><p> Investors are weighing a trove of economic releases this morning. The Labor Department reported that initial jobless claims&nbsp;totaled 205,000, sustaining a downward trend&nbsp;from the highs of their pandemic peak and reflecting labor market tightness brought on by a demand for workers heading into the new year. The latest print brings the four-week moving average for new claims to its lowest in 52 years, ticking up by 2,750 week-over-week to reach 206,250.</p><p><blockquote>投资者今天上午正在权衡一系列经济数据。美国劳工部报告称，首次申请失业救济人数总计20.5万人，较疫情峰值保持下降趋势，反映出进入新的一年对工人的需求带来的劳动力市场紧张。最新数据显示，新申请失业救济人数的四周移动平均值降至52年来的最低水平，周环比增加2,750人，达到206,250人。</blockquote></p><p> U.S. durable goods orders rose by 2.5% in November, up from the prior month, boosted by a sharp rise in aircraft orders.</p><p><blockquote>受飞机订单大幅上升提振，美国11月耐用品订单环比增长2.5%。</blockquote></p><p> Meanwhile, U.S. consumer prices&nbsp;accelerated at the fastest pace&nbsp;in nearly four decades as shoppers confront rising inflation levels ahead of the holidays.</p><p><blockquote>与此同时，由于购物者在假期前面临通胀水平上升，美国消费者价格以近四十年来最快的速度上涨。</blockquote></p><p> In Wednesday's trading session, investors weighed an upbeat print on consumer confidence levels and the release of an upwardly revised estimate for domestic GDP, placing all three major averages in the green after a mixed open.</p><p><blockquote>在周三的交易时段，投资者权衡了消费者信心水平的乐观情绪和国内GDP预估上调的发布，三大股指在开盘涨跌互现后均呈绿色。</blockquote></p><p> The Conference Board reported consumer confidence&nbsp;increased by a greater-than-expected margin in December,with the headline index at 115.8 during the month and higher than Bloomberg’s consensus estimates of 111.0. In November, the index had a reading of 111.9, revised from an initial report of 109.5. Meanwhile, the nation’s gross domestic product grew at an annual rate of 2.3% in the third quarter in the final estimate from the Bureau of Economic Analysis after the initial report of 2.1%.</p><p><blockquote>世界大型企业联合会报告称，12月份消费者信心增幅超出预期，当月总体指数为115.8，高于彭博社普遍预期的111.0。11月份，该指数读数为111.9，高于最初报告的109.5。与此同时，经济分析局在最初报告为2.1%后，最终估计第三季度美国国内生产总值年增长率为2.3%。</blockquote></p><p> “We’ve been saying that this is definitely a buy the dip sort of market because we expect more earnings upgrades to come,” Anik Sen, PineBridge Investments global head of equities&nbsp;told Yahoo Finance Live. “We think that the real debate should be about the length and strength of the economic cycle ahead.”</p><p><blockquote>PineBridge Investments全球股票主管阿尼克·森(Anik Sen)对雅虎财经直播表示：“我们一直在说，这绝对是一个逢低买入的市场，因为我们预计将出现更多盈利上调。”“我们认为真正的争论应该是关于未来经济周期的长度和强度。”</blockquote></p><p> The clock is also ticking on ayear-end Santa Claus Rally— one in which stocks climb higher in the final seven trading sessions of a year, plus the first two trading days of the new year. Starting tomorrow, traders will see whether 92 years of data uphold.</p><p><blockquote>年终圣诞老人反弹的时间也在流逝——股市在一年的最后七个交易日以及新年的前两个交易日攀升。从明天开始，交易者将看到92年的数据是否成立。</blockquote></p><p> For reasons unclear, over the past 92 years, the S&amp;P 500 gained 77% of the time during the year-end rally period, according to data from Sundial Capital Research. The average gain in this nine-day trading period tallied 2.66%.</p><p><blockquote>Sundial Capital Research的数据显示，出于尚不清楚的原因，在过去92年中，标普500在年终反弹期间有77%的时间上涨。这九天交易期间的平均涨幅为2.66%。</blockquote></p><p> Separately, Oppenheimer chief investment strategistJohn Stoltzfusdisclosedthe most bullish price target on the S&amp;P 500, forecasting a 14% climb to 5,330 by the end of 2022. The 38-year Wall Street veteran’s estimate beats even the most optimistic of his peers, BMO Capital Markets’s Brian Belski, who projected S&amp;P 500 5,300.</p><p><blockquote>另外，Oppenheimer首席投资策略师John Stoltzfus披露了标普500最乐观的目标价，预测到2022年底将上涨14%至5,330点。这位38岁的华尔街资深人士的预测甚至超过了最乐观的同行BMO Capital Markets的Brian Belski，后者预测标普500为5,300点。</blockquote></p><p> Meanwile, Pfizer (PFE)received authorization from the U.S. Food and Drug Administration for its at-home COVID-19 pill&nbsp;following clinical trial data that showed the treatment was 90% effective at preventing hospitalizations and deaths in high-risk patients. Shares of Pfizer gained more than 2% in Wednesday's session following the news and closed up 1.02% at $59.55 a piece.</p><p><blockquote>与此同时，辉瑞（PFE）获得了美国的授权。美国食品药品监督管理局对其家用COVID-19药丸进行了临床试验数据显示，该治疗在预防高危患者住院和死亡方面有90%的有效性。消息传出后，辉瑞股价在周三交易中上涨超过2%，收盘上涨1.02%，至每股59.55美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199712599","content_text":"All three major averages were up Thursday morning, building on back-to-back sessions of gains as fears the Omicron variant would derail economic growth cooled among investors who sold-off risky assets at the start of the week on reports of swelling case numbers.\nThe Nasdaq briefly jumped 180 points, while the Dow Industrial Average and S&P 500 also edged higher.\nInvestors are weighing a trove of economic releases this morning. The Labor Department reported that initial jobless claims totaled 205,000, sustaining a downward trend from the highs of their pandemic peak and reflecting labor market tightness brought on by a demand for workers heading into the new year. The latest print brings the four-week moving average for new claims to its lowest in 52 years, ticking up by 2,750 week-over-week to reach 206,250.\nU.S. durable goods orders rose by 2.5% in November, up from the prior month, boosted by a sharp rise in aircraft orders.\nMeanwhile, U.S. consumer prices accelerated at the fastest pace in nearly four decades as shoppers confront rising inflation levels ahead of the holidays.\nIn Wednesday's trading session, investors weighed an upbeat print on consumer confidence levels and the release of an upwardly revised estimate for domestic GDP, placing all three major averages in the green after a mixed open.\nThe Conference Board reported consumer confidence increased by a greater-than-expected margin in December,with the headline index at 115.8 during the month and higher than Bloomberg’s consensus estimates of 111.0. In November, the index had a reading of 111.9, revised from an initial report of 109.5. Meanwhile, the nation’s gross domestic product grew at an annual rate of 2.3% in the third quarter in the final estimate from the Bureau of Economic Analysis after the initial report of 2.1%.\n“We’ve been saying that this is definitely a buy the dip sort of market because we expect more earnings upgrades to come,” Anik Sen, PineBridge Investments global head of equities told Yahoo Finance Live. “We think that the real debate should be about the length and strength of the economic cycle ahead.”\nThe clock is also ticking on ayear-end Santa Claus Rally— one in which stocks climb higher in the final seven trading sessions of a year, plus the first two trading days of the new year. Starting tomorrow, traders will see whether 92 years of data uphold.\nFor reasons unclear, over the past 92 years, the S&P 500 gained 77% of the time during the year-end rally period, according to data from Sundial Capital Research. The average gain in this nine-day trading period tallied 2.66%.\nSeparately, Oppenheimer chief investment strategistJohn Stoltzfusdisclosedthe most bullish price target on the S&P 500, forecasting a 14% climb to 5,330 by the end of 2022. The 38-year Wall Street veteran’s estimate beats even the most optimistic of his peers, BMO Capital Markets’s Brian Belski, who projected S&P 500 5,300.\nMeanwile, Pfizer (PFE)received authorization from the U.S. Food and Drug Administration for its at-home COVID-19 pill following clinical trial data that showed the treatment was 90% effective at preventing hospitalizations and deaths in high-risk patients. Shares of Pfizer gained more than 2% in Wednesday's session following the news and closed up 1.02% at $59.55 a piece.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":3702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":166130611,"gmtCreate":1623995387333,"gmtModify":1634024387543,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/166130611","repostId":"1175693382","repostType":4,"repost":{"id":"1175693382","kind":"news","pubTimestamp":1623978463,"share":"https://www.laohu8.com/m/news/1175693382?lang=zh_CN&edition=full","pubTime":"2021-06-18 09:07","market":"us","language":"en","title":"Alibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1175693382","media":"seekingalpha","summary":"Alibaba is probably the most undervalued growth stock right now.The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.The short term technical picture may be turning bullish with a potential double bottom price action signal.When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the ","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Alibaba is probably the most undervalued growth stock right now.</li>  <li>The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.</li>  <li>The short term technical picture may be turning bullish with a potential double bottom price action signal.</li>  <li>We discuss the company’s multiple growth drivers and let investors judge for themselves.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/05e63c77d4f3f3dc3d618e43044638bb\" tg-width=\"768\" tg-height=\"512\"><span>Yongyuan Dai/iStock Unreleased via Getty Images</span></p><p><blockquote><ul><li>阿里巴巴-SW可能是目前最被低估的成长型股票。</li><li>该公司在快速扩张的市场中的多种增长动力使其估值看起来更加令人困惑。</li><li>短期技术面可能会转向看涨，并出现潜在的双底价格走势信号。</li><li>我们讨论公司的多种增长动力，让投资者自行判断。</li></ul><p class=\"t-img-caption\"><span>戴永源/iStock未通过Getty Images发布</span></p></blockquote></p><p> <b>The Technical Thesis</b></p><p><blockquote><b>技术论文</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7febf6ed056b0e3bc038321cdaad9b1c\" tg-width=\"1280\" tg-height=\"782\"><span>Source: TradingView</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView</span></p></blockquote></p><p> Alibaba’s&nbsp;stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.</p><p><blockquote>自11月20日早些时候蚂蚁金服IPO被取消以来，阿里巴巴-SW的股价已经经历了可怕的8个月，股价低迷，较高点下跌了34%。当考虑其长期上升趋势的健康状况时，很明显BABA具有相对较强的上升趋势偏差，并且通常在其关键的50W MA上得到良好支撑。过去4年中唯一一次失去关键的50W MA支撑位是在2018年熊市期间，当时BABA下跌了约40%，但仍在重要的200W MA上方得到良好支撑，我们通常认为这是“最后一道防线”。现在阿里巴巴再次面临类似的情况：下跌34%，失去了50W MA，但看起来在200W MA上方得到了很好的支撑。除此之外，价格行为分析中的一个有趣观察可能会导致价格行为交易者/投资者特别看涨：潜在的双底形成。阿里巴巴的价格似乎正在经历双底，就像2018年熊市期间一样，随后强劲反弹。因此，阿里巴巴目前的水平现在可能提供一个可能的技术买入切入点。</blockquote></p><p> <b>BABA's Fundamental Thesis: Rapidly Expanding Growth Drivers</b></p><p><blockquote><b>阿里巴巴的基本论点：快速扩大增长动力</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eba49f5881708929949c30628eedc5d4\" tg-width=\"934\" tg-height=\"578\"><span>Annual GMV. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年度GMV。数据来源：公司备案</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4d6c4ed3e2402f5af52b2dea8bab411\" tg-width=\"836\" tg-height=\"517\"><span>Annual e-commerce revenue. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年电子商务收入。数据来源：公司备案</span></p></blockquote></p><p> BABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.</p><p><blockquote>阿里巴巴的GMV在短短7年内从1.68 T元增长到7.49 T元，复合年增长率为23.8%，增速确实惊人。我们还看到其GMV增长转化为收入增长，其中国商业收入从76.7亿元增长至4736.8亿元，过去10年复合年增长率为51%。虽然其国际足迹仍然相当小，但在过去10年中，其复合年增长率仍为30.42%，这一点也不慢。</blockquote></p><p> Even though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.</p><p><blockquote>尽管预计未来三年中国电子商务市场的增长速度将大幅放缓，复合年增长率为12.4%，从2021年的13.8 T元（相当于2.16 T美元）增长到2024年的19.6 T元（相当于3.06 T美元），但庞大的市场规模仍然为阿里巴巴及其最接近的竞争对手提供了巨大的增长潜力。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffe2dee43f267e1d1399c68e3ca60f36\" tg-width=\"600\" tg-height=\"371\"><span>E-commerce revenue in the U.S. Data source: Statista</span></p><p><blockquote><p class=\"t-img-caption\"><span>美国电子商务收入数据来源：Statista</span></p></blockquote></p><p> When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.</p><p><blockquote>当我们通过比较中国与美国电子商务市场的增长率和规模来更清晰地看待事物时，我们可以看到它们的规模和增长率的巨大差异，因为美国电子商务市场预计仅增长2021年至2025年的复合年增长率为4.67%，明显低于中国的12.4%。此外，美国市场的总收入预计也将达到约5630亿美元，是届时中国市场预计价值的18%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d5a8d0d8a6a2dcdf667a6f33c6c9771\" tg-width=\"1280\" tg-height=\"702\"><span>Peers EBIT Margin and Projected EBIT Margin. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行息税前利润率和预计息税前利润率。数据来源：标普资本智商</span></p></blockquote></p><p> Even though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&amp;A, and therefore skewed its EBIT margin to the downside.</p><p><blockquote>尽管阿里巴巴-SW一直面临着来自快速增长的主要竞争对手京东（纳斯达克：JD）和拼多多（纳斯达克：PDD）的越来越大的竞争压力，但阿里巴巴已经在经营利润更高的业务（息税前利润和自由现金流），并且预计未来将继续实现强劲的盈利能力，这将使该公司具有巨大的灵活性，可以与京东和拼多多正面竞争，以扩大其领导地位。投资者可能会注意到，阿里巴巴的息税前利润率受到其SG&amp;A中反映的27.82亿美元一次性行政罚款的影响，因此其息税前利润率出现下行。</blockquote></p><p></p><p> One important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of&nbsp;823M AAC&nbsp;in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only&nbsp;100M AAC in Q2’C17&nbsp;as compared to BABA’s 466M AAC in the same period.</p><p><blockquote>一项重要举措是该公司决定进一步投资社区市场，这是拼多多的主要电子商务战略，拼多多在最近一个季度总共获得了8.23亿AAC，而阿里巴巴的AAC为8.91亿。与阿里巴巴同期的4.66亿AAC相比，拼多多的AAC在2017年第二季度仅有1亿AAC，其AAC增长确实是惊人的。</blockquote></p><p> Therefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.</p><p><blockquote>因此，增长势头肯定已经转向社区市场领域，阿里巴巴需要拿出重磅炸弹（它已经拥有）来与拼多多和京东争夺主导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b83b69b08b1f4b11a26393c8e6eead5\" tg-width=\"600\" tg-height=\"371\"><span>Market size of community group buying in China. Data source: iiMedia Research</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国社区团购的市场规模。数据来源：艾媒咨询</span></p></blockquote></p><p> Even though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.</p><p><blockquote>尽管预计到2022年1020亿元的总市场规模仅占阿里巴巴21财年中国商业收入的21.5%左右，但阿里巴巴不能错过2019年至2022年3年内44.22%的预期快速复合年增长率。虽然市场还比较小，但BABA不能让这个市场目前的龙头：PDD在旁人无知的情况下，如此轻易地称霸并吞噬早期的高增长率。当然，阿里巴巴必须竞争并争取自己在这一领域的地位，并争取早期领导地位，以防止拼多多扩大领先优势。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b97b2b4a8a182dc9846d8fb7e4039877\" tg-width=\"1280\" tg-height=\"770\"><span>PDD profitability metrics &amp; revenue growth forecast. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>PDD盈利指标和收入增长预测。数据来源：标普资本智商</span></p></blockquote></p><p> We could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.</p><p><blockquote>我们可以从上图中观察到，拼多多的收入预计将在未来几年继续快速增长，尽管预计随后将正常化。更重要的是，拼多多预计未来的息税前利润和自由现金流盈利能力也将日益提高。这表明，社区市场细分市场是一个非常重要的增长动力，阿里巴巴必须利用其优势来利用它，以否认拼多多在游戏早期声称的无可争议的领导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3aadc32155b4108426a1a982e3b5b1c2\" tg-width=\"640\" tg-height=\"360\"><span>China public cloud spending. Source:China Internet Watch; Canalys</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云支出。来源：中国互联网观察；Canalys</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c1538b9f7bdc8d6d35a72d9acf8ecbc\" tg-width=\"600\" tg-height=\"371\"><span>Size of China public cloud market. Data source: CAICT; Sina.com.cn</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云市场规模。数据来源：中国信通技术；新浪网</span></p></blockquote></p><p> BABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.</p><p><blockquote>阿里巴巴在中国公有云市场拥有40%的份额，远远领先于其主要竞争对手。然而，值得注意的是，尽管处于领先地位，阿里巴巴仍处于大力投资模式，以继续扩大其市场份额，因为中国公共云市场预计将从2017年的264.8亿元增长到2023年的2307.4亿元，这将代表CAGR 43.4%，这是一个令人难以置信的出色增长率。当我们将中国的增长率与全球增长率（见下文）进行比较时，这一点尤其明显，因为全球公共云支出预计将从2017年的1450亿美元增长到2022年的3970亿美元，这将代表22.3%的CAGR。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/06198c569504bc303c34563041dfb294\" tg-width=\"600\" tg-height=\"371\"><span>Worldwide public cloud spending. Data source: Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云支出。数据来源：Gartner</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8482037f60575f964053ab732496bee3\" tg-width=\"1176\" tg-height=\"700\"><span>Worldwide public cloud market share. Source:CnTechPost; Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云市场份额。来源：CnTechPost；Gartner</span></p></blockquote></p><p> Therefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.</p><p><blockquote>因此，阿里云在2020年以9.5%的市场份额继续扩大对Alphabet（纳斯达克：GOOGL）（纳斯达克：GOOG）GCP的领先优势，我并不觉得奇怪。虽然亚马逊仍然是市场上明显的领导者，但随着公共云支出的持续扩大，其市场份额一直在大幅下降，这表明多个参与者存在巨大的增长潜力。凭借阿里巴巴在快速扩张的中国市场的领导地位，我越来越看好该细分市场未来的利润和自由现金流对阿里巴巴业绩的贡献。尽管阿里巴巴的云部门尚未实现息税前利润（21财年息税前利润率：-15%，20财年息税前利润率：-17.5%），但值得注意的是，Alphabet的GCP也尚未实现盈利（20财年息税前利润率：-42.9%，19财年息税前利润率：-52%）。因此，我们需要给阿里巴巴一些时间来扩大其在亚太地区和中国的云服务规模，预计阿里巴巴将拥有更强大的领导力，使其能够更快地增长，投资者应该预计随着时间的推移，这将是一个高利润的细分市场。</blockquote></p><p> <b>BABA's Valuations Look Highly Compelling</b></p><p><blockquote><b>阿里巴巴的估值看起来非常引人注目</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62a087c4b3ef7efc2c5dde813e3b959d\" tg-width=\"1000\" tg-height=\"600\"><span>NTM TEV / EBIT 3Y range.</span></p><p><blockquote><p class=\"t-img-caption\"><span>NTM TEV/EBIT 3Y范围。</span></p></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2605c0e5ad364a7a43929fef204595c\" tg-width=\"1280\" tg-height=\"687\"><span>EV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>EV/Fwd息税前利润和EV/Fwd Rev趋势。数据来源：标普资本智商</span></p></blockquote></p><p> When we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.</p><p><blockquote>当我们考虑阿里巴巴的TEV/EBIT历史范围（3年平均值为33.54倍）时，阿里巴巴的EV/Fwd EBIT趋势无疑意味着该股票被严重低估，因为预计阿里巴巴的收入和营业利润仍将快速增长。然而，由于我们希望更清楚地了解其同行的估值情况，我们认为如果我们对阿里巴巴的息税前利润进行估值，而不是下面介绍的一组基准公司，这将是有用的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d27873e676dfb23c98d4a69aa5861e02\" tg-width=\"1280\" tg-height=\"1117\"><span>Peers EV / EBIT Valuations. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行EV/EBIT估值。数据来源：标普资本智商</span></p></blockquote></p><p> By using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.</p><p><blockquote>通过混合使用历史和远期息税前利润，我们可以看到，与基准公司一组观察值的中值相比，阿里巴巴的EV/EBIT看起来确实被低估了。我们得出阿里巴巴的公允价值范围为294.98美元，位于该范围的中点，基于当前210美元的股价，这意味着40.5%的潜在上涨空间。</blockquote></p><p> <b>Risks to Assumptions</b></p><p><blockquote><b>假设风险</b></blockquote></p><p> Now, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.</p><p><blockquote>现在，看着先生如何表现显然令人困惑。市场决定对阿里巴巴进行折扣，就好像该公司已经失去了所有关键的增长来源，而事实上，其商业部门、新的市场举措和不断增长的阿里云部门仍有很大的潜在上涨空间，其中。我们认为该股表现不佳的主要现实原因只是监管风险。我们认为投资者应该承认这种风险是非常真实的，有时大型中国公司会发现自己受到中国政府的额外审查（事实上这并不是什么新鲜事）。这里关键的是，中国政府似乎对其科技巨头的行为和行动拥有重大影响力，而这些影响力有时可能在很大程度上是不可预测的。市场当然讨厌不可预测性，因此他们可能会因此大幅折扣阿里巴巴。如果投资者无法应对潜在不可预测的监管行动及其后果的不确定性，那么阿里巴巴可能不适合您。然而，如果你认为这只是阿里巴巴漫长旅程中的一个短暂时刻，那么你肯定会发现阿里巴巴现在的估值极具吸引力，再加上长期思维。</blockquote></p><p> <b>Wrapping It All Up</b></p><p><blockquote><b>把这一切包起来</b></blockquote></p><p> Alibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.</p><p><blockquote>阿里巴巴-SW继续取得稳健的业绩，展示了公司强大的执行能力。由于该公司继续在一个拥有如此多增长动力的市场中运营，预计将推动公司未来的增长，投资者应该会发现当前的估值非常有吸引力。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba Stock: The Bottoming Process Looks To Be Forming Already<blockquote>阿里巴巴-SW股票：触底过程似乎已经形成</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2021-06-18 09:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Alibaba is probably the most undervalued growth stock right now.</li>  <li>The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.</li>  <li>The short term technical picture may be turning bullish with a potential double bottom price action signal.</li>  <li>We discuss the company’s multiple growth drivers and let investors judge for themselves.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/05e63c77d4f3f3dc3d618e43044638bb\" tg-width=\"768\" tg-height=\"512\"><span>Yongyuan Dai/iStock Unreleased via Getty Images</span></p><p><blockquote><ul><li>阿里巴巴-SW可能是目前最被低估的成长型股票。</li><li>该公司在快速扩张的市场中的多种增长动力使其估值看起来更加令人困惑。</li><li>短期技术面可能会转向看涨，并出现潜在的双底价格走势信号。</li><li>我们讨论公司的多种增长动力，让投资者自行判断。</li></ul><p class=\"t-img-caption\"><span>戴永源/iStock未通过Getty Images发布</span></p></blockquote></p><p> <b>The Technical Thesis</b></p><p><blockquote><b>技术论文</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7febf6ed056b0e3bc038321cdaad9b1c\" tg-width=\"1280\" tg-height=\"782\"><span>Source: TradingView</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView</span></p></blockquote></p><p> Alibaba’s&nbsp;stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.</p><p><blockquote>自11月20日早些时候蚂蚁金服IPO被取消以来，阿里巴巴-SW的股价已经经历了可怕的8个月，股价低迷，较高点下跌了34%。当考虑其长期上升趋势的健康状况时，很明显BABA具有相对较强的上升趋势偏差，并且通常在其关键的50W MA上得到良好支撑。过去4年中唯一一次失去关键的50W MA支撑位是在2018年熊市期间，当时BABA下跌了约40%，但仍在重要的200W MA上方得到良好支撑，我们通常认为这是“最后一道防线”。现在阿里巴巴再次面临类似的情况：下跌34%，失去了50W MA，但看起来在200W MA上方得到了很好的支撑。除此之外，价格行为分析中的一个有趣观察可能会导致价格行为交易者/投资者特别看涨：潜在的双底形成。阿里巴巴的价格似乎正在经历双底，就像2018年熊市期间一样，随后强劲反弹。因此，阿里巴巴目前的水平现在可能提供一个可能的技术买入切入点。</blockquote></p><p> <b>BABA's Fundamental Thesis: Rapidly Expanding Growth Drivers</b></p><p><blockquote><b>阿里巴巴的基本论点：快速扩大增长动力</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eba49f5881708929949c30628eedc5d4\" tg-width=\"934\" tg-height=\"578\"><span>Annual GMV. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年度GMV。数据来源：公司备案</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4d6c4ed3e2402f5af52b2dea8bab411\" tg-width=\"836\" tg-height=\"517\"><span>Annual e-commerce revenue. Data source: Company filings</span></p><p><blockquote><p class=\"t-img-caption\"><span>年电子商务收入。数据来源：公司备案</span></p></blockquote></p><p> BABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.</p><p><blockquote>阿里巴巴的GMV在短短7年内从1.68 T元增长到7.49 T元，复合年增长率为23.8%，增速确实惊人。我们还看到其GMV增长转化为收入增长，其中国商业收入从76.7亿元增长至4736.8亿元，过去10年复合年增长率为51%。虽然其国际足迹仍然相当小，但在过去10年中，其复合年增长率仍为30.42%，这一点也不慢。</blockquote></p><p> Even though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.</p><p><blockquote>尽管预计未来三年中国电子商务市场的增长速度将大幅放缓，复合年增长率为12.4%，从2021年的13.8 T元（相当于2.16 T美元）增长到2024年的19.6 T元（相当于3.06 T美元），但庞大的市场规模仍然为阿里巴巴及其最接近的竞争对手提供了巨大的增长潜力。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffe2dee43f267e1d1399c68e3ca60f36\" tg-width=\"600\" tg-height=\"371\"><span>E-commerce revenue in the U.S. Data source: Statista</span></p><p><blockquote><p class=\"t-img-caption\"><span>美国电子商务收入数据来源：Statista</span></p></blockquote></p><p> When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.</p><p><blockquote>当我们通过比较中国与美国电子商务市场的增长率和规模来更清晰地看待事物时，我们可以看到它们的规模和增长率的巨大差异，因为美国电子商务市场预计仅增长2021年至2025年的复合年增长率为4.67%，明显低于中国的12.4%。此外，美国市场的总收入预计也将达到约5630亿美元，是届时中国市场预计价值的18%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d5a8d0d8a6a2dcdf667a6f33c6c9771\" tg-width=\"1280\" tg-height=\"702\"><span>Peers EBIT Margin and Projected EBIT Margin. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行息税前利润率和预计息税前利润率。数据来源：标普资本智商</span></p></blockquote></p><p> Even though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&amp;A, and therefore skewed its EBIT margin to the downside.</p><p><blockquote>尽管阿里巴巴-SW一直面临着来自快速增长的主要竞争对手京东（纳斯达克：JD）和拼多多（纳斯达克：PDD）的越来越大的竞争压力，但阿里巴巴已经在经营利润更高的业务（息税前利润和自由现金流），并且预计未来将继续实现强劲的盈利能力，这将使该公司具有巨大的灵活性，可以与京东和拼多多正面竞争，以扩大其领导地位。投资者可能会注意到，阿里巴巴的息税前利润率受到其SG&amp;A中反映的27.82亿美元一次性行政罚款的影响，因此其息税前利润率出现下行。</blockquote></p><p></p><p> One important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of&nbsp;823M AAC&nbsp;in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only&nbsp;100M AAC in Q2’C17&nbsp;as compared to BABA’s 466M AAC in the same period.</p><p><blockquote>一项重要举措是该公司决定进一步投资社区市场，这是拼多多的主要电子商务战略，拼多多在最近一个季度总共获得了8.23亿AAC，而阿里巴巴的AAC为8.91亿。与阿里巴巴同期的4.66亿AAC相比，拼多多的AAC在2017年第二季度仅有1亿AAC，其AAC增长确实是惊人的。</blockquote></p><p> Therefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.</p><p><blockquote>因此，增长势头肯定已经转向社区市场领域，阿里巴巴需要拿出重磅炸弹（它已经拥有）来与拼多多和京东争夺主导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b83b69b08b1f4b11a26393c8e6eead5\" tg-width=\"600\" tg-height=\"371\"><span>Market size of community group buying in China. Data source: iiMedia Research</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国社区团购的市场规模。数据来源：艾媒咨询</span></p></blockquote></p><p> Even though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.</p><p><blockquote>尽管预计到2022年1020亿元的总市场规模仅占阿里巴巴21财年中国商业收入的21.5%左右，但阿里巴巴不能错过2019年至2022年3年内44.22%的预期快速复合年增长率。虽然市场还比较小，但BABA不能让这个市场目前的龙头：PDD在旁人无知的情况下，如此轻易地称霸并吞噬早期的高增长率。当然，阿里巴巴必须竞争并争取自己在这一领域的地位，并争取早期领导地位，以防止拼多多扩大领先优势。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b97b2b4a8a182dc9846d8fb7e4039877\" tg-width=\"1280\" tg-height=\"770\"><span>PDD profitability metrics &amp; revenue growth forecast. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>PDD盈利指标和收入增长预测。数据来源：标普资本智商</span></p></blockquote></p><p> We could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.</p><p><blockquote>我们可以从上图中观察到，拼多多的收入预计将在未来几年继续快速增长，尽管预计随后将正常化。更重要的是，拼多多预计未来的息税前利润和自由现金流盈利能力也将日益提高。这表明，社区市场细分市场是一个非常重要的增长动力，阿里巴巴必须利用其优势来利用它，以否认拼多多在游戏早期声称的无可争议的领导地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3aadc32155b4108426a1a982e3b5b1c2\" tg-width=\"640\" tg-height=\"360\"><span>China public cloud spending. Source:China Internet Watch; Canalys</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云支出。来源：中国互联网观察；Canalys</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c1538b9f7bdc8d6d35a72d9acf8ecbc\" tg-width=\"600\" tg-height=\"371\"><span>Size of China public cloud market. Data source: CAICT; Sina.com.cn</span></p><p><blockquote><p class=\"t-img-caption\"><span>中国公有云市场规模。数据来源：中国信通技术；新浪网</span></p></blockquote></p><p> BABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.</p><p><blockquote>阿里巴巴在中国公有云市场拥有40%的份额，远远领先于其主要竞争对手。然而，值得注意的是，尽管处于领先地位，阿里巴巴仍处于大力投资模式，以继续扩大其市场份额，因为中国公共云市场预计将从2017年的264.8亿元增长到2023年的2307.4亿元，这将代表CAGR 43.4%，这是一个令人难以置信的出色增长率。当我们将中国的增长率与全球增长率（见下文）进行比较时，这一点尤其明显，因为全球公共云支出预计将从2017年的1450亿美元增长到2022年的3970亿美元，这将代表22.3%的CAGR。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/06198c569504bc303c34563041dfb294\" tg-width=\"600\" tg-height=\"371\"><span>Worldwide public cloud spending. Data source: Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云支出。数据来源：Gartner</span></p></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8482037f60575f964053ab732496bee3\" tg-width=\"1176\" tg-height=\"700\"><span>Worldwide public cloud market share. Source:CnTechPost; Gartner</span></p><p><blockquote><p class=\"t-img-caption\"><span>全球公共云市场份额。来源：CnTechPost；Gartner</span></p></blockquote></p><p> Therefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.</p><p><blockquote>因此，阿里云在2020年以9.5%的市场份额继续扩大对Alphabet（纳斯达克：GOOGL）（纳斯达克：GOOG）GCP的领先优势，我并不觉得奇怪。虽然亚马逊仍然是市场上明显的领导者，但随着公共云支出的持续扩大，其市场份额一直在大幅下降，这表明多个参与者存在巨大的增长潜力。凭借阿里巴巴在快速扩张的中国市场的领导地位，我越来越看好该细分市场未来的利润和自由现金流对阿里巴巴业绩的贡献。尽管阿里巴巴的云部门尚未实现息税前利润（21财年息税前利润率：-15%，20财年息税前利润率：-17.5%），但值得注意的是，Alphabet的GCP也尚未实现盈利（20财年息税前利润率：-42.9%，19财年息税前利润率：-52%）。因此，我们需要给阿里巴巴一些时间来扩大其在亚太地区和中国的云服务规模，预计阿里巴巴将拥有更强大的领导力，使其能够更快地增长，投资者应该预计随着时间的推移，这将是一个高利润的细分市场。</blockquote></p><p> <b>BABA's Valuations Look Highly Compelling</b></p><p><blockquote><b>阿里巴巴的估值看起来非常引人注目</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62a087c4b3ef7efc2c5dde813e3b959d\" tg-width=\"1000\" tg-height=\"600\"><span>NTM TEV / EBIT 3Y range.</span></p><p><blockquote><p class=\"t-img-caption\"><span>NTM TEV/EBIT 3Y范围。</span></p></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2605c0e5ad364a7a43929fef204595c\" tg-width=\"1280\" tg-height=\"687\"><span>EV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>EV/Fwd息税前利润和EV/Fwd Rev趋势。数据来源：标普资本智商</span></p></blockquote></p><p> When we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.</p><p><blockquote>当我们考虑阿里巴巴的TEV/EBIT历史范围（3年平均值为33.54倍）时，阿里巴巴的EV/Fwd EBIT趋势无疑意味着该股票被严重低估，因为预计阿里巴巴的收入和营业利润仍将快速增长。然而，由于我们希望更清楚地了解其同行的估值情况，我们认为如果我们对阿里巴巴的息税前利润进行估值，而不是下面介绍的一组基准公司，这将是有用的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d27873e676dfb23c98d4a69aa5861e02\" tg-width=\"1280\" tg-height=\"1117\"><span>Peers EV / EBIT Valuations. Data source: S&amp;P Capital IQ</span></p><p><blockquote><p class=\"t-img-caption\"><span>同行EV/EBIT估值。数据来源：标普资本智商</span></p></blockquote></p><p> By using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.</p><p><blockquote>通过混合使用历史和远期息税前利润，我们可以看到，与基准公司一组观察值的中值相比，阿里巴巴的EV/EBIT看起来确实被低估了。我们得出阿里巴巴的公允价值范围为294.98美元，位于该范围的中点，基于当前210美元的股价，这意味着40.5%的潜在上涨空间。</blockquote></p><p> <b>Risks to Assumptions</b></p><p><blockquote><b>假设风险</b></blockquote></p><p> Now, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.</p><p><blockquote>现在，看着先生如何表现显然令人困惑。市场决定对阿里巴巴进行折扣，就好像该公司已经失去了所有关键的增长来源，而事实上，其商业部门、新的市场举措和不断增长的阿里云部门仍有很大的潜在上涨空间，其中。我们认为该股表现不佳的主要现实原因只是监管风险。我们认为投资者应该承认这种风险是非常真实的，有时大型中国公司会发现自己受到中国政府的额外审查（事实上这并不是什么新鲜事）。这里关键的是，中国政府似乎对其科技巨头的行为和行动拥有重大影响力，而这些影响力有时可能在很大程度上是不可预测的。市场当然讨厌不可预测性，因此他们可能会因此大幅折扣阿里巴巴。如果投资者无法应对潜在不可预测的监管行动及其后果的不确定性，那么阿里巴巴可能不适合您。然而，如果你认为这只是阿里巴巴漫长旅程中的一个短暂时刻，那么你肯定会发现阿里巴巴现在的估值极具吸引力，再加上长期思维。</blockquote></p><p> <b>Wrapping It All Up</b></p><p><blockquote><b>把这一切包起来</b></blockquote></p><p> Alibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.</p><p><blockquote>阿里巴巴-SW继续取得稳健的业绩，展示了公司强大的执行能力。由于该公司继续在一个拥有如此多增长动力的市场中运营，预计将推动公司未来的增长，投资者应该会发现当前的估值非常有吸引力。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now\">seekingalpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-W"},"source_url":"https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175693382","content_text":"Summary\n\nAlibaba is probably the most undervalued growth stock right now.\nThe company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.\nThe short term technical picture may be turning bullish with a potential double bottom price action signal.\nWe discuss the company’s multiple growth drivers and let investors judge for themselves.\n\nYongyuan Dai/iStock Unreleased via Getty Images\nThe Technical Thesis\nSource: TradingView\nAlibaba’s stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.\nBABA's Fundamental Thesis: Rapidly Expanding Growth Drivers\nAnnual GMV. Data source: Company filings\nAnnual e-commerce revenue. Data source: Company filings\nBABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.\nEven though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.\nE-commerce revenue in the U.S. Data source: Statista\nWhen we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.\nPeers EBIT Margin and Projected EBIT Margin. Data source: S&P Capital IQ\nEven though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&A, and therefore skewed its EBIT margin to the downside.\nOne important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of 823M AAC in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only 100M AAC in Q2’C17 as compared to BABA’s 466M AAC in the same period.\nTherefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.\nMarket size of community group buying in China. Data source: iiMedia Research\nEven though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.\nPDD profitability metrics & revenue growth forecast. Data source: S&P Capital IQ\nWe could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.\nChina public cloud spending. Source:China Internet Watch; Canalys\nSize of China public cloud market. Data source: CAICT; Sina.com.cn\nBABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.\nWorldwide public cloud spending. Data source: Gartner\nWorldwide public cloud market share. Source:CnTechPost; Gartner\nTherefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.\nBABA's Valuations Look Highly Compelling\nNTM TEV / EBIT 3Y range.\nEV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&P Capital IQ\nWhen we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.\nPeers EV / EBIT Valuations. Data source: S&P Capital IQ\nBy using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.\nRisks to Assumptions\nNow, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.\nWrapping It All Up\nAlibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.","news_type":1,"symbols_score_info":{"BABA":0.9,"09988":0.9}},"isVote":1,"tweetType":1,"viewCount":2645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166139318,"gmtCreate":1623995422434,"gmtModify":1634024386945,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166139318","repostId":"2144742925","repostType":4,"isVote":1,"tweetType":1,"viewCount":2670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340849768,"gmtCreate":1617377440354,"gmtModify":1631885696928,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ABNB\">$Airbnb, Inc.(ABNB)$</a>oh no","listText":"<a href=\"https://laohu8.com/S/ABNB\">$Airbnb, Inc.(ABNB)$</a>oh no","text":"$Airbnb, Inc.(ABNB)$oh no","images":[{"img":"https://static.tigerbbs.com/752d6e2d7c572d64f1b330d4a8c5e1bc","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/340849768","isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":317960766,"gmtCreate":1612407329655,"gmtModify":1703761418966,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317960766","repostId":"1150284862","repostType":4,"isVote":1,"tweetType":1,"viewCount":152,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":698952511,"gmtCreate":1640286571653,"gmtModify":1640286571653,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562111968746343","authorIdStr":"3562111968746343"},"themes":[],"htmlText":"Go9oooooood","listText":"Go9oooooood","text":"Go9oooooood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698952511","repostId":"1152565085","repostType":4,"repost":{"id":"1152565085","kind":"news","pubTimestamp":1640272176,"share":"https://www.laohu8.com/m/news/1152565085?lang=zh_CN&edition=full","pubTime":"2021-12-23 23:09","market":"us","language":"en","title":"Intel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152565085","media":"Bloomberg","summary":"(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in Fran","content":"<p>(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations.</p><p><blockquote>（彭博社）-据知情人士透露，英特尔公司在全球范围内提高产能的努力将包括在法国和意大利增加工厂，以及在德国建立一个主要生产基地。</blockquote></p><p> France will be home to a research and design center, and Italy will be the location of a test and assembly factory, according to the people, who asked not to be identified because the plan hasn’t been announced. The main wafer fabrication plant, or fab, will likely be built in Germany, according to the people. Altogether, the expansion will cost tens of billions of dollars.</p><p><blockquote>据知情人士透露，法国将成为研究和设计中心的所在地，意大利将成为测试和组装工厂的所在地。由于该计划尚未公布，这些知情人士要求匿名。据知情人士透露，主要的晶圆制造厂（fab）可能会建在德国。总的来说，扩建将耗资数百亿美元。</blockquote></p><p> Chief Executive Officer Pat Gelsinger is trying to restore the world’s largest chipmaker to its former glory. The company has lost its technological edge to rivals and ceded market share -- something the spending binge is meant to address. Gelsinger also wants to bring more production back to the U.S. and Europe, counterbalancing Asia’s manufacturing dominance.</p><p><blockquote>首席执行官帕特·基辛格(Pat Gelsinger)正试图让这家全球最大的芯片制造商恢复昔日的辉煌。该公司已经将技术优势输给了竞争对手，并放弃了市场份额——这正是支出狂潮旨在解决的问题。基辛格还希望将更多生产带回美国和欧洲，抵消亚洲的制造业主导地位。</blockquote></p><p> Representatives of the French, German and Italian governments declined to comment, as did Intel spokespeople in Europe and the U.S.</p><p><blockquote>法国、德国和意大利政府代表拒绝置评，英特尔在欧洲和美国的发言人也拒绝置评。</blockquote></p><p> For Europe, the move would slow its decline as a manufacturing base in the $400 billion chip industry. The U.S. company has an existing plant in Ireland and there are older former Advanced Micro Devices Inc. processor factories that are owned by Globalfoundries Inc. in Dresden, Germany. But European manufacturers typically don’t make the kind of advanced logic chips that are regarded as the state of the art in the industry.</p><p><blockquote>对于欧洲来说，此举将减缓其作为4000亿美元芯片行业制造基地的衰落。这家美国公司在爱尔兰有一家现有工厂，在德国德累斯顿还有Globalfoundries Inc.拥有的较老的前Advanced Micro Devices Inc.处理器工厂。但欧洲制造商通常不生产被视为业内最先进的先进逻辑芯片。</blockquote></p><p> NXP Semiconductors NV and STMicroelectronics NV are the continent’s two largest homegrown chipmakers. They focus on parts for cars and other equipment -- rather than the advanced computer processors that are Intel’s specialty.</p><p><blockquote>恩智浦半导体公司和意法半导体公司是非洲大陆最大的两家本土芯片制造商。他们专注于汽车和其他设备的零部件，而不是英特尔擅长的先进计算机处理器。</blockquote></p><p> A global chip shortage also has renewed concerns about the concentration of production in Asia. Manufacturers such as Taiwan Semiconductor Manufacturing Co. and South Korea’s Samsung Electronics Co. have grown increasingly deft at producing chips, forcing Intel to play catch-up. Gelsinger has argued that spreading manufacturing around the world will help avoid the kinds of supply constraints that have hobbled whole industries this year, including automakers.</p><p><blockquote>全球芯片短缺也重新引发了人们对生产集中在亚洲的担忧。台积电公司和三星电子公司等制造商在生产芯片方面越来越熟练，迫使英特尔奋起直追。基辛格认为，将制造业扩展到世界各地将有助于避免今年阻碍包括汽车制造商在内的整个行业的供应限制。</blockquote></p><p> Part of Gelsinger’s plan is to build factories that make chips for other companies, directly rivaling TSMC in the so-called foundry business. Until now, Intel has typically only manufactured chips of its own design.</p><p><blockquote>基辛格计划的一部分是建立为其他公司制造芯片的工厂，在所谓的代工业务上直接与台积电竞争。到目前为止，英特尔通常只制造自己设计的芯片。</blockquote></p><p> To help fund his ambitions, he’s called on lawmakers on both sides of the Atlantic to give public money in the form of tax breaks and grants to chipmakers willing to build plants in Europe and the U.S.</p><p><blockquote>为了资助他的雄心，他呼吁大西洋两岸的立法者以税收减免和拨款的形式向愿意在欧洲和美国建厂的芯片制造商提供公共资金。</blockquote></p><p> By spreading around Intel’s spending, Gelsinger may be trying to placate as many EU members as he can to try to make sure that none of them try to object any central funding that’s made available. But the plans aren’t final yet. The mega-fab will likely be built in Saxony, with German regions of Saxony-Anhalt and Bavaria also in the running for the new factory.</p><p><blockquote>通过分散英特尔的支出，基辛格可能试图安抚尽可能多的欧盟成员国，以确保他们中没有人试图反对任何可用的中央资金。但是计划还没有最终确定。该大型工厂可能会建在萨克森州，德国萨克森-安哈尔特州和巴伐利亚州也在争夺新工厂。</blockquote></p><p> Intel’s ambitious new ventures could bring thousands of jobs. The company is also planning to create 4,000 jobs in Malaysia via a $7.1 billion investment in new chip packaging facilities.</p><p><blockquote>英特尔雄心勃勃的新企业可能会带来数千个就业机会。该公司还计划通过投资71亿美元建设新的芯片封装设施，在马来西亚创造4,000个就业岗位。</blockquote></p><p> Intel’s shares increased 1.2% in early trading Thursday.</p><p><blockquote>英特尔股价周四早盘上涨1.2%。</blockquote></p><p> Even with the potential government help, Intel is budgeting as much as $28 billion for new plants and equipment in 2022, up from roughly $18 billion this year. The spending plans have jarred investors, who worry about the toll on profit. But the massive increase in expenditures will only put Intel on course to keep up with TSMC and Samsung’s spending.</p><p><blockquote>即使有政府的潜在帮助，英特尔2022年的新工厂和设备预算仍高达280亿美元，高于今年的约180亿美元。这些支出计划令投资者感到不安，他们担心利润会受到影响。但支出的大幅增加只会让英特尔跟上台积电和三星的支出。</blockquote></p><p> Shares of Intel, based in Santa Clara, California, have gained just 2.3% this year -- even as its peers have enjoyed boom times. The Philadelphia Stock Exchange Semiconductor Index has climbed 39%, with companies such as Nvidia Corp. more than doubling.</p><p><blockquote>总部位于加利福尼亚州圣克拉拉的英特尔股价今年仅上涨了2.3%，尽管其同行经历了繁荣时期。费城证券交易所半导体指数上涨了39%，英伟达公司等公司的股价上涨了一倍多。</blockquote></p><p> State-of-the art chip production plants cost more than $20 billion, and their most expensive component -- machinery -- is usually obsolete within five years. The German plant could have a price tag in that range. The Italian test and assembly plant, meanwhile, will cost around $10 billion. Intel and government officials there are still negotiating on the site, with Sicily being one area under consideration, according to one of the people familiar with the situation.</p><p><blockquote>最先进的芯片生产厂耗资超过200亿美元，其最昂贵的部件——机械——通常会在五年内过时。德国工厂的价格标签可能在这个范围内。与此同时，意大利测试和装配厂将耗资约100亿美元。据一位知情人士透露，英特尔和那里的政府官员仍在就该地点进行谈判，西西里岛是正在考虑的地区之一。</blockquote></p><p> The French R&amp;D center may be built in either Paris or Grenoble, according to another person. Such facilities typically cost only a fraction of the amount needed to build a factory.</p><p><blockquote>另一位人士称，法国研发中心可能建在巴黎或格勒诺布尔。此类设施的成本通常仅为建造工厂所需费用的一小部分。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel to Expand in France, Germany and Italy in Comeback<blockquote>英特尔将在法国、德国和意大利扩张</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-23 23:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations.</p><p><blockquote>（彭博社）-据知情人士透露，英特尔公司在全球范围内提高产能的努力将包括在法国和意大利增加工厂，以及在德国建立一个主要生产基地。</blockquote></p><p> France will be home to a research and design center, and Italy will be the location of a test and assembly factory, according to the people, who asked not to be identified because the plan hasn’t been announced. The main wafer fabrication plant, or fab, will likely be built in Germany, according to the people. Altogether, the expansion will cost tens of billions of dollars.</p><p><blockquote>据知情人士透露，法国将成为研究和设计中心的所在地，意大利将成为测试和组装工厂的所在地。由于该计划尚未公布，这些知情人士要求匿名。据知情人士透露，主要的晶圆制造厂（fab）可能会建在德国。总的来说，扩建将耗资数百亿美元。</blockquote></p><p> Chief Executive Officer Pat Gelsinger is trying to restore the world’s largest chipmaker to its former glory. The company has lost its technological edge to rivals and ceded market share -- something the spending binge is meant to address. Gelsinger also wants to bring more production back to the U.S. and Europe, counterbalancing Asia’s manufacturing dominance.</p><p><blockquote>首席执行官帕特·基辛格(Pat Gelsinger)正试图让这家全球最大的芯片制造商恢复昔日的辉煌。该公司已经将技术优势输给了竞争对手，并放弃了市场份额——这正是支出狂潮旨在解决的问题。基辛格还希望将更多生产带回美国和欧洲，抵消亚洲的制造业主导地位。</blockquote></p><p> Representatives of the French, German and Italian governments declined to comment, as did Intel spokespeople in Europe and the U.S.</p><p><blockquote>法国、德国和意大利政府代表拒绝置评，英特尔在欧洲和美国的发言人也拒绝置评。</blockquote></p><p> For Europe, the move would slow its decline as a manufacturing base in the $400 billion chip industry. The U.S. company has an existing plant in Ireland and there are older former Advanced Micro Devices Inc. processor factories that are owned by Globalfoundries Inc. in Dresden, Germany. But European manufacturers typically don’t make the kind of advanced logic chips that are regarded as the state of the art in the industry.</p><p><blockquote>对于欧洲来说，此举将减缓其作为4000亿美元芯片行业制造基地的衰落。这家美国公司在爱尔兰有一家现有工厂，在德国德累斯顿还有Globalfoundries Inc.拥有的较老的前Advanced Micro Devices Inc.处理器工厂。但欧洲制造商通常不生产被视为业内最先进的先进逻辑芯片。</blockquote></p><p> NXP Semiconductors NV and STMicroelectronics NV are the continent’s two largest homegrown chipmakers. They focus on parts for cars and other equipment -- rather than the advanced computer processors that are Intel’s specialty.</p><p><blockquote>恩智浦半导体公司和意法半导体公司是非洲大陆最大的两家本土芯片制造商。他们专注于汽车和其他设备的零部件，而不是英特尔擅长的先进计算机处理器。</blockquote></p><p> A global chip shortage also has renewed concerns about the concentration of production in Asia. Manufacturers such as Taiwan Semiconductor Manufacturing Co. and South Korea’s Samsung Electronics Co. have grown increasingly deft at producing chips, forcing Intel to play catch-up. Gelsinger has argued that spreading manufacturing around the world will help avoid the kinds of supply constraints that have hobbled whole industries this year, including automakers.</p><p><blockquote>全球芯片短缺也重新引发了人们对生产集中在亚洲的担忧。台积电公司和三星电子公司等制造商在生产芯片方面越来越熟练，迫使英特尔奋起直追。基辛格认为，将制造业扩展到世界各地将有助于避免今年阻碍包括汽车制造商在内的整个行业的供应限制。</blockquote></p><p> Part of Gelsinger’s plan is to build factories that make chips for other companies, directly rivaling TSMC in the so-called foundry business. Until now, Intel has typically only manufactured chips of its own design.</p><p><blockquote>基辛格计划的一部分是建立为其他公司制造芯片的工厂，在所谓的代工业务上直接与台积电竞争。到目前为止，英特尔通常只制造自己设计的芯片。</blockquote></p><p> To help fund his ambitions, he’s called on lawmakers on both sides of the Atlantic to give public money in the form of tax breaks and grants to chipmakers willing to build plants in Europe and the U.S.</p><p><blockquote>为了资助他的雄心，他呼吁大西洋两岸的立法者以税收减免和拨款的形式向愿意在欧洲和美国建厂的芯片制造商提供公共资金。</blockquote></p><p> By spreading around Intel’s spending, Gelsinger may be trying to placate as many EU members as he can to try to make sure that none of them try to object any central funding that’s made available. But the plans aren’t final yet. The mega-fab will likely be built in Saxony, with German regions of Saxony-Anhalt and Bavaria also in the running for the new factory.</p><p><blockquote>通过分散英特尔的支出，基辛格可能试图安抚尽可能多的欧盟成员国，以确保他们中没有人试图反对任何可用的中央资金。但是计划还没有最终确定。该大型工厂可能会建在萨克森州，德国萨克森-安哈尔特州和巴伐利亚州也在争夺新工厂。</blockquote></p><p> Intel’s ambitious new ventures could bring thousands of jobs. The company is also planning to create 4,000 jobs in Malaysia via a $7.1 billion investment in new chip packaging facilities.</p><p><blockquote>英特尔雄心勃勃的新企业可能会带来数千个就业机会。该公司还计划通过投资71亿美元建设新的芯片封装设施，在马来西亚创造4,000个就业岗位。</blockquote></p><p> Intel’s shares increased 1.2% in early trading Thursday.</p><p><blockquote>英特尔股价周四早盘上涨1.2%。</blockquote></p><p> Even with the potential government help, Intel is budgeting as much as $28 billion for new plants and equipment in 2022, up from roughly $18 billion this year. The spending plans have jarred investors, who worry about the toll on profit. But the massive increase in expenditures will only put Intel on course to keep up with TSMC and Samsung’s spending.</p><p><blockquote>即使有政府的潜在帮助，英特尔2022年的新工厂和设备预算仍高达280亿美元，高于今年的约180亿美元。这些支出计划令投资者感到不安，他们担心利润会受到影响。但支出的大幅增加只会让英特尔跟上台积电和三星的支出。</blockquote></p><p> Shares of Intel, based in Santa Clara, California, have gained just 2.3% this year -- even as its peers have enjoyed boom times. The Philadelphia Stock Exchange Semiconductor Index has climbed 39%, with companies such as Nvidia Corp. more than doubling.</p><p><blockquote>总部位于加利福尼亚州圣克拉拉的英特尔股价今年仅上涨了2.3%，尽管其同行经历了繁荣时期。费城证券交易所半导体指数上涨了39%，英伟达公司等公司的股价上涨了一倍多。</blockquote></p><p> State-of-the art chip production plants cost more than $20 billion, and their most expensive component -- machinery -- is usually obsolete within five years. The German plant could have a price tag in that range. The Italian test and assembly plant, meanwhile, will cost around $10 billion. Intel and government officials there are still negotiating on the site, with Sicily being one area under consideration, according to one of the people familiar with the situation.</p><p><blockquote>最先进的芯片生产厂耗资超过200亿美元，其最昂贵的部件——机械——通常会在五年内过时。德国工厂的价格标签可能在这个范围内。与此同时，意大利测试和装配厂将耗资约100亿美元。据一位知情人士透露，英特尔和那里的政府官员仍在就该地点进行谈判，西西里岛是正在考虑的地区之一。</blockquote></p><p> The French R&amp;D center may be built in either Paris or Grenoble, according to another person. Such facilities typically cost only a fraction of the amount needed to build a factory.</p><p><blockquote>另一位人士称，法国研发中心可能建在巴黎或格勒诺布尔。此类设施的成本通常仅为建造工厂所需费用的一小部分。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/intel-expand-france-germany-italy-091904071.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔"},"source_url":"https://finance.yahoo.com/news/intel-expand-france-germany-italy-091904071.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152565085","content_text":"(Bloomberg) -- Intel Corp.’s global push to increase capacity will include adding facilities in France and Italy, as well as putting a major production site in Germany, according to people familiar with negotiations.\nFrance will be home to a research and design center, and Italy will be the location of a test and assembly factory, according to the people, who asked not to be identified because the plan hasn’t been announced. The main wafer fabrication plant, or fab, will likely be built in Germany, according to the people. Altogether, the expansion will cost tens of billions of dollars.\nChief Executive Officer Pat Gelsinger is trying to restore the world’s largest chipmaker to its former glory. The company has lost its technological edge to rivals and ceded market share -- something the spending binge is meant to address. Gelsinger also wants to bring more production back to the U.S. and Europe, counterbalancing Asia’s manufacturing dominance.\nRepresentatives of the French, German and Italian governments declined to comment, as did Intel spokespeople in Europe and the U.S.\nFor Europe, the move would slow its decline as a manufacturing base in the $400 billion chip industry. The U.S. company has an existing plant in Ireland and there are older former Advanced Micro Devices Inc. processor factories that are owned by Globalfoundries Inc. in Dresden, Germany. But European manufacturers typically don’t make the kind of advanced logic chips that are regarded as the state of the art in the industry.\nNXP Semiconductors NV and STMicroelectronics NV are the continent’s two largest homegrown chipmakers. They focus on parts for cars and other equipment -- rather than the advanced computer processors that are Intel’s specialty.\nA global chip shortage also has renewed concerns about the concentration of production in Asia. Manufacturers such as Taiwan Semiconductor Manufacturing Co. and South Korea’s Samsung Electronics Co. have grown increasingly deft at producing chips, forcing Intel to play catch-up. Gelsinger has argued that spreading manufacturing around the world will help avoid the kinds of supply constraints that have hobbled whole industries this year, including automakers.\nPart of Gelsinger’s plan is to build factories that make chips for other companies, directly rivaling TSMC in the so-called foundry business. Until now, Intel has typically only manufactured chips of its own design.\nTo help fund his ambitions, he’s called on lawmakers on both sides of the Atlantic to give public money in the form of tax breaks and grants to chipmakers willing to build plants in Europe and the U.S.\nBy spreading around Intel’s spending, Gelsinger may be trying to placate as many EU members as he can to try to make sure that none of them try to object any central funding that’s made available. But the plans aren’t final yet. The mega-fab will likely be built in Saxony, with German regions of Saxony-Anhalt and Bavaria also in the running for the new factory.\nIntel’s ambitious new ventures could bring thousands of jobs. The company is also planning to create 4,000 jobs in Malaysia via a $7.1 billion investment in new chip packaging facilities.\nIntel’s shares increased 1.2% in early trading Thursday.\nEven with the potential government help, Intel is budgeting as much as $28 billion for new plants and equipment in 2022, up from roughly $18 billion this year. The spending plans have jarred investors, who worry about the toll on profit. But the massive increase in expenditures will only put Intel on course to keep up with TSMC and Samsung’s spending.\nShares of Intel, based in Santa Clara, California, have gained just 2.3% this year -- even as its peers have enjoyed boom times. The Philadelphia Stock Exchange Semiconductor Index has climbed 39%, with companies such as Nvidia Corp. more than doubling.\nState-of-the art chip production plants cost more than $20 billion, and their most expensive component -- machinery -- is usually obsolete within five years. The German plant could have a price tag in that range. The Italian test and assembly plant, meanwhile, will cost around $10 billion. Intel and government officials there are still negotiating on the site, with Sicily being one area under consideration, according to one of the people familiar with the situation.\nThe French R&D center may be built in either Paris or Grenoble, according to another person. Such facilities typically cost only a fraction of the amount needed to build a factory.","news_type":1,"symbols_score_info":{"INTC":0.9}},"isVote":1,"tweetType":1,"viewCount":2493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}